| Sr. N0. | Generic/Brand Name | Compositions | Ph. Ref. | Strength |
|---|---|---|---|---|
| 1 | Slow Diclofenac Tablets BP | Each Film Coated Sustained released Tablet Contains: Diclofenac Sodium, Approved Colour used, Excipients qs | IP | 75 mg |
| 2 | Pantoprazole Sodium with Domperidone Gastro-resistant Tablets | Each Gastro-resistant tablet Contains: Pantoprazole Sodium sesquihydrate Eq. to Pantoprazole, Domperidone, Approved Colour used, Excipients qs | IP IP | 40 mg, 10 mg |
| 3 | Ferrous Ascorbate, Folic Acid and Zinc Sulphate Tablets | Each Film Coated Tablet Contains: Ferrous Ascorbate (Eq. to Elemental Iron), Folic Acid, Zinc Sulphate Monohydrate (Eq. to Elemental Zinc), Approved Colour used, Excipients qs | IP IP | 100 mg, 1.5 mg, 61.8 mg, 22.5 mg |
| 4 | Calcium carbonate and Vitamin D3 Tablets IP | Each film Coated Tablet Contains: Calcium Carbonate (From Organic oyster shell, Eq. to Elemental Calcium), Vitamin D3, Approved Colour used, Excipients qs | IP IP | 1250 mg, 500 mg, 250 I.U. |
| 5 | Telmisartan Tablet IP | Each Uncoated Tablet Contains: Telmisartan, Excipients qs | IP | 40 mg |
| 6 | Domperidone Dispersible Tablet | Each Uncoated Dispersible Tablet Contains: Domperidone, Excipients qs | IP | 10 mg |
| 7 | Aceclofenac and Paracetamol Tablet | Each Film Coated Tablet Contains: Aceclofenac, Paracetamol, Approved Colour used, Excipients qs | IP IP | 100 mg, 325 mg |
| 8 | Nimesulide and Paracetamol Tablet | Each Uncoated Tablet Contains: Nimesulide, Paracetamol, Excipients qs | BP IP | 100 mg, 325 mg |
| 9 | Drotaverine HCL and Mefenamic Acid Tablet | Each Film Coated Tablet Contains: Drotaverine Hydrochloride (Eq. to Drotaverine), Mefenamic Acid, Approved Colour used, Excipients qs | IP IP | 80 mg, 250 mg |
| 10 | Levocetirizine Hydrochloride and Montelukast Tablet IP | Each Film Coated Tablet Contains: Levocetirizine Dihydrochloride, Montelukast Sodium (Eq. to Montelukast), Approved Colour used, Excipients qs | IP IP | 2.5 mg, 4 mg |
| 11 | Metformin Hydrochloride Prolonged Release and Glimepiride Tablet IP | Each uncoated bilayered Tablet contains: Glimepiride, Metformin Hydrochloride (In Prolonged release form), Excipients q.s., Approved colour used | IP IP | 2 mg, 500 mg |
| 12 | Metformin Hydrochloride Prolonged Release and Glimepiride Tablet IP | Each uncoated bilayered Tablet contains: Glimepiride, Metformin Hydrochloride (In Prolonged release form), Excipients q.s., Approved colour used | IP IP | 1 mg, 500 mg |
| 13 | Amlodipine Besylate Telmisartan and Hydrochlorothiazide Tablet | Each Film coated Tablet contains: Amlodipine Besylate (Eq. to Amlodipine), Telmisartan, Hydrochlorothiazide, Excipients q.s., Approved colour used | IP IP IP | 10 mg, 80 mg, 25 mg |
| 14 | Amlodipine Besylate Telmisartan and Hydrochlorothiazide Tablet | Each Film coated Tablet contains: Amlodipine Besylate (Eq. to Amlodipine), Telmisartan, Hydrochlorothiazide, Excipients q.s., Approved colour used | IP IP IP | 5 mg, 40 mg, 12.5 mg |
| 15 | Amlodipine Besylate Telmisartan and Hydrochlorothiazide Tablet | Each Film coated Tablet contains: Amlodipine Besylate (Eq. to Amlodipine), Telmisartan, Hydrochlorothiazide, Excipients q.s., Approved colour used | IP IP IP | 2.5 mg, 20 mg, 12.5 mg |
| 16 | Levetiracetam Tablet IP | Each Film coated Tablet Contains: Levetiracetam, Excipients q.s., Approved colour used | IP | 500 mg |
| 17 | Gabapentin Tablet | Each Film coated Tablet Contains: Gabapentin, Excipients q.s., Approved colour used | IP | 300 mg |
| 18 | Methylcobalamin Tablet USP | Each Film coated Tablet Contains: Methylcobalamin, Excipients q.s., Approved colour used | IP | 500 mcg |
| 19 | Methylcobalamin Tablet USP | Each Film coated Tablet Contains: Methylcobalamin, Excipients q.s., Approved colour used | IP | 1000 mcg |
| 20 | Trypsin, Bromelain, Rutoside Trihydrate & Diclofenac Sodium Tablet | Each Enteric coated Tablet Contains: Trypsin, Bromelain, Rutoside Trihydrate, Diclofenac Sodium, Excipients q.s., Approved colour used | BP BP IP | 48 mg, 90 mg, 100 mg, 50 mg |
| 21 | Pregabalin, Nortriptyline & Methylcobalamin Tablet | Each Film coated Tablet Contains: Pregabalin, Nortriptyline Hydrochloride (Eq. to Nortriptyline), Methylcobalamin, Excipients q.s., Approved colour used | IP IP IP | 75 mg, 10 mg, 1500 mcg |
| 22 | Ivermectin Tablet USP | Each Uncoated Tablet Contains: Ivermectin, Excipients q.s., Approved colour used | IP | 6 mg |
| 23 | Ivermectin Tablet USP | Each Uncoated Tablet Contains: Ivermectin, Excipients q.s., Approved colour used | IP | 12 mg |
| 24 | Sparfloxacin Tablet | Each Film coated Tablet Contains: Sparfloxacin, Excipients q.s., Approved colour used | – | 200 mg |
| 25 | Aceclofenac, Paracetamol, Cetirizine Hydrochloride, Phenylephrine HCL & Caffeine Tablet | Each Film coated Tablet Contains: Aceclofenac, Paracetamol, Cetirizine Hydrochloride, Phenylephrine Hydrochloride, Caffeine (Anhydrous), Excipients q.s., Approved colour used | IP IP IP IP IP | 100 mg, 325 mg, 10 mg, 5 mg, 25 mg |
| 26 | Metformin Hydrochloride, Glimepiride and Pioglitazone Bilayer Tablet | Each Uncoated Bilayer Tablet Contains: Metformin Hydrochloride (Sustained release), Glimepiride, Pioglitazone Hydrochloride (Eq. to Pioglitazone), Excipients q.s., Approved colour used | IP IP IP | 500 mg, 2 mg, 15 mg |
| 27 | Doxylamine Succinate, Pyridoxine Hydrochloride and Folic Acid Tablets | Each Gastro-resistant Tablet Contains: Doxylamine Succinate, Pyridoxine Hydrochloride, Folic Acid, Excipients q.s., Approved colour used | USP IP IP | 20 mg, 20 mg, 5 mg |
| 28 | Aceclofenac, Paracetamol and Thiocolchicoside Tablet | Each Film coated Tablet Contains: Aceclofenac, Paracetamol, Thiocolchicoside, Excipients q.s., Approved colour used | IP IP IP | 100 mg, 325 mg, 4 mg |
| 29 | Levosulpiride Tablet | Each Uncoated Tablet Contains: Levosulpiride, Excipients q.s., Approved colour used | – | 25 mg |
| 30 | Citicoline Sodium and Piracetam Tablets | Each Film coated Tablet Contains: Citicoline Sodium (Eq. to Citicoline), Piracetam, Excipients q.s., Approved colour used | IP IP | 500 mg, 800 mg |
| 31 | Melatonin Tablet | Each Uncoated Tablet contains: Melatonin, Excipients q.s. | BP | 3 mg |
| 32 | Calcitriol, Calcium Citrate, Zinc Sulphate and Magnesium Hydroxide Tablet | Each Film Coated Tablet Contains: Calcitriol, Calcium Citrate, Zinc Sulphate Monohydrate (Eq. to Elemental Zinc), Magnesium Hydroxide (Eq. to Magnesium), Excipients q.s., Approved colour used | IP USP IP IP | 0.25 mcg, 1000 mg, 7.5 mg, 100 mg |
| 33 | Calcium Carbonate, Zinc Sulphate, Magnesium Hydroxide, Vitamin D3 Tablets | Each Film Coated Tablet Contains: Calcium Carbonate (Eq. to Elemental Calcium), Zinc Sulphate Monohydrate (Eq. to Elemental Zinc), Vitamin D3, Magnesium Hydroxide (Eq. to Magnesium), Excipients q.s., Approved colour used | IP IP IP IP | 500 mg, 11 mg, 200 IU, 100 mg |
| 34 | Nimesulide, Paracetamol, Phenylephrine and Caffeine Tablets | Each Uncoated Tablet Contains: Nimesulide, Paracetamol, Phenylephrine Hydrochloride, Caffeine (Anhydrous), Excipients q.s., Approved colour used | BP IP IP IP | 100 mg, 325 mg, 10 mg, 25 mg |
| 35 | Nimesulide, Paracetamol and Chlorzoxazone Tablets | Each Uncoated Tablet Contains: Nimesulide, Paracetamol, Chlorzoxazone, Excipients q.s., Approved colour used | BP IP USP | 100 mg, 325 mg, 375 mg |
| 36 | Paracetamol, Chlorpheniramine Maleate and Phenylephrine HCL Tablets | Each Uncoated Tablet Contains: Paracetamol, Chlorpheniramine Maleate, Phenylephrine Hydrochloride, Excipients q.s., Approved colour used | IP IP IP | 325 mg, 2 mg, 10 mg |
| 37 | Cilostazol Tablet IP | Each Uncoated Tablet Contains: Cilostazol, Excipients q.s., Approved colour used | IP | 100 mg |
| 38 | Cilostazol Tablet IP | Each Uncoated Tablet Contains: Cilostazol, Excipients q.s., Approved colour used | IP | 50 mg |
| 39 | Azithromycin & Lactic Acid Bacillus Tablets | Each Film Coated Tablet Contains: Azithromycin Dihydrate (Eq. to Azithromycin), Lactic Acid Bacillus, Excipients q.s., Approved colour used | IP | 500 mg, 60 Million Spores |
| 40 | Azithromycin & Lactic Acid Bacillus Tablets | Each Film Coated Tablet Contains: Azithromycin Dihydrate (Eq. to Azithromycin), Lactic Acid Bacillus, Excipients q.s., Approved colour used | IP | 250 mg, 60 Million Spores |
| 41 | Dapagliflozin and Metformin HCl Extended Release Tablet | Each Film Coated Tablet Contains: Dapagliflozin Propanediol Monohydrate Eq. to Dapagliflozin, Metformin Hydrochloride (In Extended Release Form), Excipients q.s. | IP | 10 mg, 500 mg |
| 42 | Dapagliflozin and Metformin HCl Extended Release Tablet | Each Film Coated Tablet Contains: Dapagliflozin Propanediol Monohydrate Eq. to Dapagliflozin, Metformin Hydrochloride (In Extended Release Form), Excipients q.s. | IP | 10 mg, 1000 mg |
| 43 | Cabergoline Tablet IP | Each Uncoated Tablet Contains: Cabergoline, Excipients q.s. | IP | 0.5 mg |
| 44 | Gabapentin and Nortriptyline Hydrochloide Tablets | Each Film Coated Tablet Contains: Gabapentin, Nortriptyline Hydrochloride Eq. to Nortriptyline, Excipients q.s., Approved colour used. | IP IP | 400 mg, 10 mg |
| 45 | Trypsin, Bromelain and Rutoside Trihydrate Tablets | Each enteric coated tablet contains: Trypsin, Bromelain, Rutoside Trihydrate, Excipients q.s. | BP BP | 96 mg, 180 mg, 200 mg |
| 46 | Sitagliptin Phosphate and Metformin HCl Tablet | Each Film coated Tablet Contains: Sitagliptin Phosphate Monohydrate Eq. to Sitagliptin, Metformin Hydrochloride (As Sustained Release), Excipients q.s. | IP IP | 50 mg, 500 mg |
| 47 | Sitagliptin Phosphate and Metformin HCl Tablet | Each Film coated Tablet Contains: Sitagliptin Phosphate Monohydrate Eq. to Sitagliptin, Metformin Hydrochloride (As Sustained Release), Excipients q.s. | IP IP | 50 mg, 1000 mg |
| 48 | Sitagliptin Phosphate and Metformin HCl Tablet | Each Film coated Tablet Contains: Sitagliptin Phosphate Monohydrate Eq. to Sitagliptin, Metformin Hydrochloride (As Sustained Release), Excipients q.s. | IP IP | 50 mg, 850 mg |
| 49 | Sitagliptin Phosphate Tablet IP | Each Film coated Tablet Contains: Sitagliptin Phosphate Monohydrate Eq. to Sitagliptin, Excipients q.s. | IP | 25 mg |
| 50 | Sitagliptin Phosphate Tablet IP | Each Film coated Tablet Contains: Sitagliptin Phosphate Monohydrate Eq. to Sitagliptin, Excipients q.s. | IP | 50 mg |
| 51 | Sitagliptin Phosphate Tablet IP | Each Film coated Tablet Contains: Sitagliptin Phosphate Monohydrate Eq. to Sitagliptin, Excipients q.s. | IP | 100 mg |
| 52 | Oxcarbazepine Tablets | Each Film Coated Tablet Contains: Oxcarbazepine, Excipients q.s., Approved colour used. | IP | 150 mg |
| 53 | Oxcarbazepine Tablets | Each Film Coated Tablet Contains: Oxcarbazepine, Excipients q.s., Approved colour used. | IP | 300 mg |
| 54 | Tofacitinib Tablet | Each Film Coated Tablet Contains: Tofacitinib Citrate Eq. to Tofacitinib, Excipients q.s., Approved colour used. | 5 mg | |
| 55 | Ivabradine Hydrochloride Tablet | Each Film Coated Tablet Contains: Ivabradine Hydrochloride Eq. to Ivabradine, Excipients q.s., Approved colour used. | 5 mg | |
| 56 | Ranolazine Extended Release Tablets | Each Film Coated Extended Release Tablet Contains: Ranolazine, Excipients q.s., Colour: Approved Colour | 500 mg | |
| 57 | Ethamsylate and Tranexamic Tablets | Each Film Coated Tablet Contains: Tranexamic Acid, Ethamsylate, Excipients q.s., Colour: Approved Colour | BP BP | 250 mg, 250 mg |
| 58 | Silodosin Tablet | Each Film Coated Tablet Contains: Silodosin, Excipients q.s., Approved colour used. | 4 mg | |
| 59 | Metaxalone and Diclofenac Potassium Tablets | Each Uncoated Tablet Contains: Diclofenac Potassium, Metaxalone, Excipients q.s., Approved colour used. | BP USP | 50 mg, 400 mg |
| 60 | Acotiamide Hydrochloride Tablet | Each Film Coated Tablet Contains: Acotiamide Hydrochloride Hydrate, Excipients q.s., Approved colour used. | 100 mg | |
| 61 | Etodolac Tablet | Each Film Coated Tablet Contains: Etodolac, Excipients q.s. | IP | 200 mg |
| 62 | Etodolac Tablet | Each Film Coated Tablet Contains: Etodolac, Excipients q.s. | IP | 300 mg |
| 63 | Etodolac Tablet | Each Film Coated Tablet Contains: Etodolac, Excipients q.s. | IP | 400 mg |
| 64 | Paracetamol, Phenylephrine HCL & Chlorpheniramine Maleate Tablets | Each Uncoated Tablet Contains: Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate, Excipients q.s. | IP IP IP | 500 mg, 10 mg, 2 mg |
| 65 | Metformin HCl (SR) and Glimepiride Tablet | Each uncoated Tablet Contains: Metformin Hydrochloride (As sustained release form), Glimepiride, Excipients q.s. | IP IP | 1000 mg, 2 mg |
| 66 | Methylprednisolone Tablet IP | Each uncoated Tablet Contains: Methylprednisolone, Excipients q.s. | IP | 16 mg |
| 67 | Methylprednisolone Tablet IP | Each uncoated Tablet Contains: Methylprednisolone, Excipients q.s. | IP | 8 mg |
| 68 | Metformin Hydrochloride (SR) Tablet IP | Each Film coated sustained release tablet contains: Metformin Hydrochloride (In sustained release form), Excipients q.s., Approved colour used. | IP | 500 mg |
| 69 | Etoricoxib Tablets IP | Each Film coated Tablet Contains: Etoricoxib, Excipients q.s., Approved colour used | IP | 120 mg |
| 70 | Ursodeoxycholic Acid Tablet IP | Each uncoated tablet contains: Ursodeoxycholic Acid, Excipients q.s. | IP | 300 mg |
| 71 | Metformin Hydrochloride (SR) Tablet IP | Each uncoated sustained release tablet contains: Metformin Hydrochloride (In sustained release form), Excipients q.s., Approved colour used | IP | 500 mg |
| 72 | Aciclovir Dispersible Tablets IP | Each Uncoated Dispersible Tablet contains: Aciclovir, Excipients q.s., Approved colour used | IP | 200 mg |
| 73 | Diacerein and Aceclofenac Tablet | Each Film coated tablet contains: Diacerein, Aceclofenac, Excipients q.s., Approved colour used | IP IP | 50 mg, 100 mg |
| 74 | Desloratadine Tablet | Each Film coated tablet contains: Desloratadine, Excipients q.s., Approved colour used | 5 mg | |
| 75 | Biotin Tablet | Each Film coated tablet contains: Biotin, Excipients q.s., Approved colour used | USP | 5 mg |
| 76 | Ciprofloxacin and Tinidazole Tablet | Each Film coated tablet contains: Ciprofloxacin Hydrochloride Eq. to Ciprofloxacin, Tinidazole, Excipients q.s., Approved colour used | IP IP | 500 mg, 600 mg |
| 77 | Pantoprazole Sodium with Domperidone Tablets | Each Gastro-resistant Tablet Contains: Pantoprazole Sodium Sesquihydrate Eq. to Pantoprazole, Domperidone, Excipients q.s., Approved colour used | IP IP | 40 mg, 10 mg |
| 78 | Voglibose Tablet IP | Each Uncoated Tablet contains: Voglibose, Excipients q.s. | IP | 0.2 mg |
| 79 | Aceclofenac and Tizanidine Tablet | Each Film Coated Tablet contains: Aceclofenac, Tizanidine Hydrochloride Eq. to Tizanidine, Excipients q.s., Approved colour used | IP IP | 100 mg, 2 mg |
| 80 | Rosuvastatin Tablet IP | Each Film coated tablet contains: Rosuvastatin Calcium Eq. to Rosuvastatin, Excipients q.s., Approved colour used | IP | 20 mg |
| 81 | Pantoprazole Gastro-resistant Tablet IP | Each Gastro-resistant tablet contains: Pantoprazole Sodium Sesquihydrate Eq. to Pantoprazole, Excipients q.s., Approved colour used | IP | 20 mg |
| 82 | Cephalexin Tablet IP | Each uncoated Tablet contains: Cephalexin Monohydrate Eq. to Cephalexin, Excipients q.s., Approved colour used | IP | 125 mg |
| 83 | Ampicillin Tablet IP | Each Uncoated Tablet contains: Ampicillin Trihydrate Eq. to Ampicillin, Excipients q.s., Approved colour used | IP | 125 mg |
| 84 | Doxofylline Tablet IP | Each Uncoated Tablet contains: Doxofylline, Excipients q.s. | IP | 400 mg |
| 85 | Tadalafil Tablet IP | Each Film coated Tablet contains: Tadalafil, Excipients q.s., Approved colour used | IP | 20 mg |
| 86 | Cetirizine Tablet IP | Each Film coated Tablet Contains: Cetirizine Hydrochloride, Excipients q.s. | IP | 10 mg |
| 87 | Telmisartan and Amlodipine Besilate Tablet IP | Each Film coated tablet contains: Telmisartan, Amlodipine Besilate Eq. to Amlodipine, Excipients q.s., Approved colour used | IP IP | 40 mg, 5 mg |
| 88 | Metformin Hydrochloride Tablet IP | Each uncoated Tablet contains: Metformin Hydrochloride, Excipients q.s. | IP | 500 mg |
| 89 | Terbinafine Hydrochloride Tablet IP | Each Uncoated Tablet Contains: Terbinafine Hydrochloride Eq. to Terbinafine, Excipients q.s. | IP | 250 mg |
| 90 | Cotrimoxazole Tablet IP | Each Uncoated Tablet contains: Trimethoprim, Sulphamethoxazole, Excipients q.s. | IP IP | 160 mg, 800 mg |
| 91 | Glimepiride and Metformin Hydrochloride (SR) Tablet | Each Uncoated Tablet Contains: Glimepiride, Metformin Hydrochloride (As Sustained Release form), Excipients q.s. | IP IP | 1 mg, 1000 mg |
| 92 | Glimepiride and Metformin Hydrochloride (SR) Tablet | Each Uncoated Tablet Contains: Glimepiride, Metformin Hydrochloride (As Sustained Release form), Excipients q.s. | IP IP | 2 mg, 1000 mg |
| 93 | Mecobalamin, Folic Acid and Pyridoxine HCl Tablet | Each Film coated Tablet contains: Mecobalamin, Folic Acid, Pyridoxine Hydrochloride, Excipients q.s., Approved colour used | IP IP IP | 1500 mcg, 5 mg, 20 mg |
| 94 | Rosuvastatin Calcium and Fenofibrate Tablet | Each Film coated Tablet contains: Rosuvastatin Calcium Eq. to Rosuvastatin, Fenofibrate, Excipients q.s., Approved colour used | IP IP | 5 mg, 67 mg |
| 95 | Amitriptyline Tablet IP | Each Film Coated Tablet contains: Amitriptyline Hydrochloride, Excipients q.s., Approved colour used | IP | 10 mg |
| 96 | Amitriptyline Tablet IP | Each Film Coated Tablet contains: Amitriptyline Hydrochloride, Excipients q.s., Approved colour used | IP | 25 mg |
| 97 | Rosuvastatin Tablet IP | Each Film coated Tablet contains: Rosuvastatin Calcium Eq. to Rosuvastatin, Excipients q.s., Approved colour used | IP | 10 mg |
| 98 | Hydroxyzine Hydrochloride Tablet IP | Each Film coated Tablet contains: Hydroxyzine Hydrochloride, Excipients q.s., Approved colour used | IP | 10 mg |
| 99 | Hydroxyzine Hydrochloride Tablet IP | Each Film coated Tablet contains: Hydroxyzine Hydrochloride Excipients qs Approved colour used | IP | 25 mg |
| 100 | Metformin Hydrochloride (Sustained Release) Tablet IP | Each Uncoated Tablet Contains: Metformin Hydrochloride (Sustained Release) Excipients qs Approved colour used | IP | 1000 mg |
| 101 | Levothyroxin Sodium Tablet IP | Each Uncoated Tablet Contains: Levothyroxin Sodium Eq. to Levothyroxin Anhydrous Excipients qs | IP | 25 mcg |
| 102 | Ferrous Ascorbate, Folic Acid, Methylcobalamin And Zinc Tablet | Each Film coated tablet contains: Ferrous Ascorbate Eq. to elemental Iron Folic Acid Methylcobalamin Zinc Sulphate Monohydrate Eq. to elemental Zinc Approved colour used | IP IP IP | 100 mg, 1.1 mg, 1.5 mg, 22.5 mg |
| 103 | Aciclovir Tablet IP | Each Uncoated Tablet Contains: Aciclovir Excipients qs | IP | 800 mg |
| 104 | Fluconazole Tablet IP | Each Uncoated Tablet Contains: Fluconazole Excipients qs | IP | 150 mg |
| 105 | Multivitamin Tablet | Each Film coated Tablet Contains: Vitamin A (As Acetate form), Vitamin B2, Vitamin C, Vitamin D3, Vitamin B1, Niacinamide, Vitamin B12, Vitamin E(As Acetate form) Excipients qs Approved colour used | IP IP IP IP IP IP IP IP | 10 mg, 5 mg, 50 mg, 400 IU, 10 mg, 50 mg, 5 mcg, 25 IU |
| 106 | Trypsin, Bromelain and Rutoside Trihydrate Tablets | Each enteric coated tablet contains: Trypsin, Bromelain, Rutoside Trihydrate, Excipients qs | BP BP | 48 mg, 90 mg, 100 mg |
| 107 | Dicyclomine Hydrochloride Tablet | Each uncoated Tablet Contains: Dicyclomine Hydrochloride Excipients qs | IP | 10 mg |
| 108 | Fluconazole Tablet IP | Each Uncoated Tablet contains: Fluconazole Excipients qs | IP | 200 mg |
| 109 | Voglibose and Metformin Tablets | Each Uncoated Tablet Contains: Voglibose Metformin Hydrochloride Excipients qs | IP IP | 0.2 mg, 500 mg |
| 110 | Haloperidol Tablets | Each Film Coated Tablet Contains: Haloperidol Excipients qs Approved colour used. | IP | 20 mg |
| 111 | Tranexamic Acid and Mefenamic Acid Tablets | Each Film Coated Tablet Contains: Tranexamic Acid Mefenamic Acid Excipients qs Approved colour used. | IP IP | 500 mg, 250 mg |
| 112 | Mefenamic Acid Tablet | Each Film Coated Tablet contains: Mefenamic Acid Excipients qs Approved colour used. | IP | 500 mg |
| 113 | Metronidazole Tablets IP | Each Uncoated Tablet contains: Metronidazole Excipients qs | IP | 400 mg |
| 114 | Betahistine Hydrochloride Tablet IP | Each Uncoated Tablet Contains: Betahistine Dihydrochloride Excipients qs | IP | 8 mg |
| 115 | Betahistine Hydrochloride Tablet IP | Each Uncoated Tablet Contains: Betahistine Dihydrochloride Excipients qs | IP | 16 mg |
| 116 | Paracetamol Tablet IP | Each Uncoated Tablet Contains: Paracetamol Excipients qs | IP | 500 mg |
| 117 | Glimepiride Tablet IP | Each Uncoated Tablet Contains: Glimepiride Excipients qs | IP | 2 mg |
| 118 | Etodolac and Thiocolchicoside Tablet | Each Film coated Tablet Contains: Etodolac Thiocolchicoside Excipients qs Approved colour used. | IP IP | 400 mg, 4 mg |
| 119 | Loratadine Tablet USP | Each Uncoated Tablet Contains: Loratadine Excipients qs | USP | 10 mg |
| 120 | Pregabalin (SR) and Methylcobalamin Tablet | Each Film coated Tablet Contains: Pregabalin (As sustained release) Methylcobalamin Excipients qs Approved colour used. | IP IP | 75 mg, 1500 mcg |
| 121 | Diclofenac Potassium and Serratiopeptidase gastro-resistant tablet | Each Gastro-resistant tablet contains: Diclofenac Potassium Serratiopeptidase Excipients qs Approved colour used. | BP IP | 50 mg, 10 mg |
| 122 | Ferrous Ascorbate and Folic Acid Tablet | Each Film coated Tablet Contains: Ferrous Ascorbate Eq. to Elemental Iron Folic Acid Excipients qs Approved colour used | IP | 100 mg, 1.5 mg |
| 123 | Paracetamol with Dicyclomine HCl Tablets | Each Uncoated Tablet contains: Paracetamol Dicyclomine HCl Excipients qs | IP IP | 325 mg, 10 mg |
| 124 | Etoricoxib Tablet IP | Each Film coated Tablet Contains: Etoricoxib Excipients qs Approved colour used | IP | 90 mg |
| 125 | Calcium Citrate and Vitamin D3 Tablet | Each Film coated Tablet Contains: Calcium Citrate Tetrahydrate Eq. to Elemental Calcium Vitamin D3 Excipients qs | USP IP | 1000 mg, 210 mg, 250 IU |
| 126 | Clidinium Bromide, Chlordiazepoxide and Dicyclomine Hydrochloride Tablet | Each Film coated Tablet Contains: Clidinium Bromide Chlordiazepoxide Dicyclomine Hydrochloride Excipients qs Approved colour used | USP IP IP | 2.5 mg, 5 mg, 10 mg |
| 127 | Diclofenac Potassium, Chlorzoxazone and Acetaminophen Tablet | Each Uncoated Tablet Contains: Diclofenac Potassium Chlorzoxazone Acetaminophen Excipients qs | BP USP IP | 50 mg, 250 mg, 325 mg |
| 128 | Amlodipine Besylate Tablet IP | Each Uncoated Tablet Contains: Amlodipine Besylate Eq. to Amlodipine Excipients qs | IP | 5 mg |
| 129 | Aceclofenac Sustained Release Tablets | Each Film Coated Sustained Release Tablet Contains: Aceclofenac Excipients qs Approved colour used | IP | 200 mg |
| 130 | Nimesulide, Paracetamol and Tizanidine HCl Tablet | Each Uncoated Tablet Contains: Nimesulide Paracetamol Tizanidine HCl Eq. to Tizanidine Excipients qs | BP IP IP | 100 mg, 325 mg, 2 mg |
| 131 | Levofloxacin Tablets IP | Each Film coated Tablet Contains: Levofloxacin Hemihydrate Eq. to Levofloxacin Approved colour used Excipients qs Approved colour used | IP | 250 mg |
| 132 | Sildenafil Citrate Tablets IP | Each Film coated Tablet Contains: Sildenafil Citrate Eq. to Sildenafil Excipients qs Approved Colour used | IP | 50 mg |
| 133 | Sildenafil Citrate Tablets IP | Each Film coated Tablet Contains: Sildenafil Citrate Eq. to Sildenafil Excipients qs Approved Colour used | IP | 100 mg |
| 134 | Nitroglycerin Sustained Release Tablets | Each Film coated Sustained Release Tablet Contains: Diluted Nitroglycerin Eq. to Nitroglycerin Excipients qs Approved Colour used | IP | 2.6 mg |
| 135 | Thyroxine Sodium Tablets IP | Each Uncoated tablet Contains: Thyroxine Sodium Eq. to Thyroxine Sodium (Anhydrous) Excipients qs | IP | 50 mcg |
| 136 | Thyroxine Sodium Tablets IP | Each Uncoated tablet Contains : Thyroxine Sodium Eq. to Thyroxine Sodium (Anhydrous) Excipients q.s | IP | 100 mcg |
| 137 | Tapentadol Hydrochloride Tablets | Each Uncoated tablet Contains : Tapentadol Hydrochloride Excipients q.s | IP | 50 mg |
| 138 | Tapentadol Hydrochloride Tablets | Each Uncoated tablet Contains : Tapentadol Hydrochloride Excipients q.s | IP | 100 mg |
| 139 | Levofloxacin Tablets IP | Each Film Coated Tablet Contains: Levofloxacin Hemihydrate Eq. to Levofloxacin Excipients q.s Approved colour used. | IP | 500 mg |
| 140 | Ofloxacin Tablets IP | Each Film Coated Tablet Contains : Ofloxacin Excipients q.s Approved colour used | IP | 400 mg |
| 141 | Isosorbide Mononitrate Tablets IP | Each Uncoated Tablet Contains : Diluted Isosorbide Mononitrate Excipients q.s | IP | 20 mg |
| 142 | Serratiopeptidase Tablets IP | Each Film Coated Tablet Contains : Serratiopeptidase Excipients q.s Approved colour used | IP | 10 mg |
| 143 | Citicoline Sodium Tablets IP | Each Film Coated Tablet Contains : Citicoline Sodium Eq. to Citicoline Excipients q.s Approved colour used | IP | 500 mg |
| 144 | Pantoprazole Sodium Gastro-resistant Tablets IP | Each Gastro-resistant Tablet Contains: Pantoprazole Sodium Sesquihydrate Eq. to Pantoprazole Excipients q.s Approved colour used. | IP | 40 mg |
| 145 | Levocetirizine Tablets IP | Each Film Coated Tablet Contains: Levocetirizine Hydrochloride Excipients q.s Approved colour used. | IP | 5 mg |
| 146 | Rabeprazole Sodium Gastro-resistant Tablets IP | Each Gastro-resistant Tablet Contains: Rabeprazole Sodium Excipients q.s Approved colour used. | IP | 20 mg |
| 147 | Montelukast Tablets IP | Each Film Coated Tablet Contains: Montelukast Sodium Eq. to Montelukast Excipients q.s Approved colour used. | IP | 10 mg |
| 148 | Ramipril and Hydrochlorothiazide Tablets IP | Each Uncoated Tablet Contains: Ramipril Hydrochlorothiazide Excipients q.s | IP IP | 2.5 mg / 12.5 mg |
| 149 | Ofloxacin Tablets IP | Each Film Coated Tablet Contains: Ofloxacin Excipients q.s Approved colour used. | IP | 200 mg |
| 150 | Aceclofenac Tablets IP | Each Film Coated Tablet Contains: Aceclofenac Approved colour used. Excipients q.s | IP | 100 mg |
| 151 | Diclofenac Potassium and Serratiopeptidase Tablets | Each Enteric Coated Tablet Contains: Diclofenac Potassium Serratiopeptidase Excipients q.s Approved colour used. | BP IP | 50 mg / 10 mg |
| 152 | Paracetamol and Domperidone Tablets | Each Film Coated Tablet Contains: Paracetamol Domperidone Excipients q.s Approved colour used. | IP IP | 325 mg / 10 mg |
| 153 | Atorvastatin Tablets IP | Each Film Coated Tablet Contains: Atorvastatin Calcium Eq. to Atorvastatin Excipients q.s Approved colour used. | IP | 10 mg |
| 154 | Deflazacort Tablets | Each Uncoated Tablet Contains: Deflazacort Excipients q.s | 30 mg | |
| 155 | Thiocolchicoside and Etoricoxib Tablets | Each Film Coated Tablet Contains: Thiocolchicoside Etoricoxib Excipients q.s Approved colour used. | IP IP | 8 mg / 60 mg |
| 156 | Piroxicam Dispersible Tablets | Each Uncoated Dispersible Tablet Contains: Piroxicam Excipients q.s | IP | 20 mg |
| 157 | Methylprednisolone Tablets IP | Each Uncoated Tablet Contains: Methylprednisolone Excipients q.s | IP | 4 mg |
| 158 | Cholecalciferol Tablets | Each Uncoated Chewable Tablet Contains: Cholecalciferol Excipients q.s | IP | 60000 IU |
| 159 | Lornoxicam and Paracetamol Tablets | Each Film Coated Tablet Contains: Lornoxicam, Paracetamol Excipients q.s Approved colour used. | IP IP | 4 mg / 325 mg |
| 160 | Lornoxicam and Paracetamol Tablets | Each Film Coated Tablet Contains: Lornoxicam, Paracetamol Excipients q.s Approved colour used. | IP IP | 8 mg / 325 mg |
| 161 | Doxylamine Succinate, Pyridoxine Hydrochloride & Folic Acid Tablet | Each Film coated Tablet Contains Doxylamine Succinate, Pyridoxine Hydrochloride, Folic Acid Approved colour used Excipients q.s | USP IP IP | 20 mg / 20 mg / 5 mg |
| 162 | Terbinafine Hydrochloride Tablet | Each Uncoated Tablet Contains: Terbinafine Hydrochloride Eq. to Terbinafine Excipients q.s | IP | 500 mg |
| 163 | Thiocolchicoside and Etoricoxib Tablet | Each Film Coated Tablet Contains: Thiocolchicoside, Etoricoxib Excipients q.s Approved colour used. | IP IP | 4 mg / 60 mg |
| 164 | Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Each Film Coated Tablet Contains: Aceclofenac, Paracetamol, Serratiopeptidase (As enteric coated granules) Eq. to 30,000 Enzymatic units of Serratiopeptidase Excipients q.s Approved colour used. | IP IP | 100 mg / 325 mg / 15 mg |
| 165 | Azithromycin Tablets IP | Each Film Coated Tablet Contains: Azithromycin Dihydrate Eq. to Azithromycin (Anhydrous) Excipients q.s Approved colour used. | IP | 250 mg |
| 166 | Calcium Carbonate and Vitamin D3 Tablets IP | Each Uncoated Tablet Contains: Calcium Carbonate (From an Organic source oyster shell) Eq. to Elemental Calcium, Vitamin D3 Approved Colour used Excipients q.s | IP IP | 1250 mg / 500 mg / 250 I.U. |
| 167 | Thiocolchicoside Tablet | Each uncoated Tablet contains: Thiocolchicoside Excipients q.s | IP | 4 mg |
| 168 | Thiocolchicoside Tablet | Each uncoated Tablet contains: Thiocolchicoside Excipients q.s | IP | 8 mg |
| 169 | Losartan Potassium Tablet IP | Each Film Coated Tablet Contains: Losartan Potassium Excipients q.s Approved colour used. | IP | 25 mg |
| 170 | Losartan Tablet IP | Each Film Coated Tablet Contains: Losartan Potassium Excipients q.s Approved colour used. | IP | 50 mg |
| 171 | Losartan Potassium and Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains: Losartan Potassium, Hydrochlorothiazide Excipients q.s Approved colour used. | IP IP | 50 mg / 12.5 mg |
| 172 | Nitrofurantoin SR Tablets 100 mg IP | Each Film Coated sustained release Tablet Contains: Nitrofurantoin Approved colour used. Excipients q.s. | IP | 100 mg |
| 173 | Calcium Citrate, Vitamin D3 Magnesium Hydroxide, Zinc Sulphate tablet. | Each Film Coated Tablet Contains: Calcium Citrate Magnesium Hydroxide Eq. to Magnesium Vitamin D3 Zinc Sulphate Monohydrate Eq. to Zinc Excipients…….q.s Approved colour used | USP IP IP IP | 1000mg 100mg 400 IU 4 mg |
| 174 | Trypsin Chymotrypsin & Aceclofenac Tablets | Each enteric coated tablet contains: 50000 armour units of enzymatic activity supplied by a purified concentrate which has specific trypsin and chymotrypsin activity in a ratio of approximately six to one Aceclofenac Approved colour used. Excipients q.s. | IP | 100 mg |
| 175 | Methylcobalamin, L-Methylfolate Calcium, & Pyridoxal-5 Phosphate Tablets | Each Film Coated Tablet Contains: Methylcobalamin L-Methylfolate Calcium Pyridoxal-5 Phosphate Approved colour used. Excipients q.s. | IP USP | 1500 mcg 1 mg 0.5 mg |
| 176 | Calcium Citrate Malate, Calcitriol, Vitamin K2-7 Tablets | Each Film Coated Tablet Contains: Calcium Citrate Malate Eq. to Elemental Calcium Calcitriol Vitamin K2-7 Approved colour used. Excipients q.s. | IP | 250 mg 0.25 mcg 50 mcg |
| 177 | Antioxidant, Multivitamin & Multiminerals Tablet | Each Film coated tablet contains : Vitamin A Acetate Vitamin E Acetate Ascorbic Acid Thiamine Monohydrate Riboflavin Pyridoxine Hydrochloride Cyanocobalamin Niacinamide Folic Acid Calcium Pantothenate Zinc Oxide Eq .to Elemental Zinc Cupric Oxide Eq .to Elemental Copper Sodium selenate Eq .to Elemental Selenium Manganese Chloride Eq .to Elemental Manganese Chromium Chloride Eq .to Elemental Chromium Excipients qs Approved colour used |
IP IP IP IP IP IP IP IP IP IP IP USP BP USP USP | 5000 IU 25 IU 100 mg 10 mg 10 mg 3 mg 5 mcg 50 mg 1 mg 12.5 mg 15 mg 2.5mg 60 mcg 1.5mg 65 mcg |
| 178 | Drotaverine Hydrochloride & Paracetamol Tablet | Each Film coated Tablet Contains Drotaverine Hydrochloride Eq. to Drotaverine Paracetamol Approved colour used Excipients qs |
IP IP | 80 mg 325 mg |
| 179 | Metformin Hydrochloride Prolonged release & Glimepiride Tablet IP | Each Film coated Tablet Contains : Metformin Hydrochloride (As prolonged release form) Glimepiride Excipients qs | IP IP | 500 mg 1 mg |
| 180 | Artemether & Lumefantrine Tablet | Each Film coated Tablet Contains Artemether Lumefantrine Approved colour used Excipients qs | IP | 80 mg 480 mg |
| 181 | Rabeprazole Sodium & Domperidone Gastro-resistant Tablet | Each Gastro-resistant Tablet Contains : Rabeprazole Sodium Domperidone Approved Colour used Excipients qs | IP IP | 20 mg 10 mg |
| 182 | Amlodipine and Atenolol Tablet | Each Uncoated Tablet Contains Amlodipine Besilate Eq. to Amlodipine Atenolol Excipients qs | IP IP | 5 mg 50 mg |
| 183 | Rabeprazole Sodium Tablet IP | Each Gastro-resistant Tablet Contains : Rabeprazole Sodium Approved Colour used Excipients qs | IP | 20 mg |
| 184 | Aceclofenac, Paracetamol, & Chlorzoxazone Tablet | Each Film coated tablet Contains Aceclofenac Paracetamol Chlorzoxazone Approved Colour used Excipients qs | IP IP USP | 100 mg 325 mg 250 mg |
| 185 | Cinnarizine & Domperidone Tablet | Each Uncoated Tablet Contains Cinnarizine Domperidone Excipients qs | IP IP | 20 mg 15 mg |
| 186 | Acetaminophen, Serratiopeptidase & Diclofenac Potassium Tablet | Each Film Coated Tablet Contains : Acetaminophen Serratiopeptidase (Eq. to 20000 Enzymatic Units) Diclofenac Potassium Approved colour used Excipients qs |
IP IP BP | 325 mg 10 mg 50 mg |
| 187 | Doxylamine Succinate, Pyridoxine Hydrochloride & Folic Acid Tablet | Each Gastro-resistant Tablet Contains Doxylamine Succinate Pyridoxine Hydrochloride Folic Acid Approved colour used Excipients qs |
USP IP IP | 10 mg 10 mg 2.5 mg |
| 188 | Mecobalamin, Folic Acid & Pyridoxine Hydrochloride Tablet | Each Film coated Tablet Contains : Mecobalamin Folic Acid Pyridoxine Hydrochloride Approved colour used Excipients qs |
IP IP IP | 1500 mcg 5 mg 20 mg |
| 189 | Ferrous Ascorbate & Folic Acid Tablets | Each Film Coated Tablet Contains : Ferrous Ascorbate Eq. to Elemental Iron Folic Acid Approved colour used Excipients qs |
IP | 100 mg 1.5 mg |
| 190 | Fluconazole Tablet | Each uncoated Tablet Contains : Fluconazole Excipients q.s. | IP | 300mg |
| 191 | Telmisartan and Hydrochlorothiazide Tablet | Each Uncoated bilayered tablet contains : Telmisartan Hydrochlorothiazide Excipients q.s Approved colour used | IP IP | 80mg 25mg |
| 192 | Ibuprofen and Paracetamol Tablet IP | Each Uncoated Tablet Contains : Ibuprofen Paracetamol Excipients q.s | IP IP | 400mg 325mg |
| 193 | Telmisartan and Amlodipine Tablet IP | Each Uncoated bilayered tablet contains : Telmisartan Amlodipine Besylate Eq. to Amlodipine Excipients q.s. Approved colour used |
IP IP | 80mg 10mg |
| 194 | Doxycycline Dispersible Tablets IP | Each Dispersible uncoated Tablet Contains : Doxycycline Hydrochloride Eq. to Doxycycline Excipients q.s. | IP | 100mg |
| 195 | Sitagliptin Tablet IP | Each uncoated Tablet Contains : Sitagliptin Phosphate Eq. to Sitagliptin Excipients q.s. | IP | 25mg |
| 196 | Sitagliptin Tablet IP | Each uncoated Tablet Contains : Sitagliptin Phosphate Eq. to Sitagliptin Excipients q.s. | IP | 50mg |
| 197 | Sitagliptin Tablet IP | Each uncoated Tablet Contains : Sitagliptin Phosphate Eq. to Sitagliptin Excipients q.s. | IP | 100mg |
| 198 | Vitamin D3 (Cholecalciferol) Orally Disintegrating Tablet 2000IU | Each Orally Disintegrating Tablet contains : Vitamin D3(Cholecalciferol) Excipients q.s. | IP | 2000 IU |
| 199 | Montelukast Orally Disintegrating Tablet 4mg | Each Film coated Tablet contains : Montelukast sodium Eq. to Montelukast Excipients q.s. Approved colour used | IP | 4mg |
| 200 | Montelukast Tablet IP 5mg | Each Film coated Tablet contains : Montelukast sodium Eq. to Montelukast Excipients q.s. Approved colour used | IP | 5mg |
| 201 | Montelukast Tablet IP 10mg | Each Film coated Tablet contains : Montelukast sodium Eq. to Montelukast Excipients q.s. Approved colour used | IP | 10mg |
| 202 | Ketorolac Tromethamine Tablet IP | “Each Film Coated Tablet contains : Ketorolac Tromethamine Excipients q.s. Approved colour used | IP | 10mg |
| 203 | Levosulpiride Tablet | Each Film Coated Tablet contains : Levosulpiride Excipients q.s. Approved colour used | 75mg | |
| 204 | Levosulpiride Tablet | Each Film Coated Tablet contains : Levosulpiride Excipients q.s. Approved colour used | 150mg | |
| 205 | Levosulpiride Tablet | Each Film Coated Tablet contains : Levosulpiride Excipients q.s. Approved colour used | 200mg | |
| 206 | Thiocolchicoside and Lornoxicam Tablet | Each Film Coated Tablet Contains : Thiocolchicoside Lornoxicam Excipients q.s. Approved colour used | IP IP | 8mg 8mg |
| 207 | Thiocolchicoside and Lornoxicam Tablet | Each Film Coated Tablet Contains : Thiocolchicoside Lornoxicam Excipients q.s. Approved colour used | IP IP | 16mg 16mg |
| 208 | Febuxostat Tablet | Each Film Coated Tablet Contains : Febuxostat Excipients q.s. Approved colour used | 40mg | |
| 209 | Methylcobalamin Tablet | Each Film coated Tablet contains : Methylcobalamin Approved colour used. Excipients q.s. | IP | 1500 mcg |
| 210 | Voglibose and Metformin Hydrochloride (SR) Tablet | Each uncoated bilayered Tablet contains: Voglibose Metformin Hydrochloride (As sustained release form) Excipients q.s. |
IP IP | 0.3mg 500mg |
| 211 | Linezolid Tablet IP | Each Film Coated Tablet Contains : Linezolid Excipients q.s. Approved colour used | IP | 600mg |
| 212 | Sodium Fusidate Ointment BP | Each Gram Contains : Sodium Fusidate In a ointment base qs | IP | 20 mg |
| 213 | Piroxicam Capsules IP | Each Hard Gelatin Capsule Contains: Piroxicam Excipients q.s | IP | 20 mg |
| 214 | Montelukast Sodium and Desloratadine Tablet | Each Film coated tablet contains : Montelukast Sodium Eq. to Montelukast Desloratadine Excipients qs Approved colour used |
IP IP | 10 mg 5mg |
| 215 | Amlodipine Besylate Tablet IP | Each Uncoated Tablet Contains : Amlodipine Besylate Eq. to Amlodipine Excipients q.s | IP | 5 mg |
| 216 | Amlodipine Besylate Tablet IP | Each Uncoated Tablet Contains : Amlodipine Besylate Eq. to Amlodipine Excipients q.s | IP | 10 mg |
| 217 | Sildenafil Citrate Tablets | Each Film coated Tablet Contains : Sildenafil Citrate Eq. to Sildenafil Excipients q.s Approved Colour used | IP | 50 mg |
| 218 | Sildenafil Citrate Tablets | Each Film coated Tablet Contains : Sildenafil Citrate Eq. to Sildenafil Excipients q.s Approved Colour used | IP | 100 mg |
| 219 | Paracetamol 500 mg Tablet | Each Uncoated Tablet Contains: Paracetamol Exicpients q.s. Approved colour used | IP | 500 mg |
| 220 | Pantoprazole & Domperidone Tablets | Composition: Each Enteric Coated Tablet Contains: Pantoprazole Sodium Sesquihydrate eq. to Pantoprazole Domperidone Excipients q.s. Approved colour used. |
IP IP | 40 mg 10 mg |
| 221 | Pantoprazole Sodium Delayed Release Tablets | Composition: Each Enteric Coated Tablet Contains: Pantoprazole Sodium Sesquihydrate eq. to Pantoprazole Excipients q.s. Approved colour used. |
IP | 40 mg |
| 222 | Ivabradine Hydrochloride Tablet | Each Film Coated Tablet Contains: Ivabradine Hydrochloride Eq. to Ivabradine Excipients qs Approved colour used. | 7.5 mg | |
| 223 | Ticagrelor Tablet | Each Film Coated Tablet Contains: Ticagrelor Excipients qs Approved colour used. | IP | 90 mg |
| 224 | Tamsulosin HCl (MR) & Dutasteride Tablet | Each Film Coated Tablet Contains: Tamsulosin Hydrochloride (as Modified Release) Dutasteride Excipients qs Approved colour used. |
IP IP | 0.4 mg 0.5 mg |
| 225 | Alfuzocin HCl (ER) & Dutasteride Tablet | Each Film Coated Tablet Contains: Alfuzocin Hydrochloride (As Extended Release Tablet) Dutasteride Excipients qs Approved colour used. |
IP IP | 10 mg 0.5 mg |
| 226 | Paroxetine Hydrochloride Tablet | Each Film Coated Tablet Contains: Paroxetine Hydrochloride Eq. to Paroxetine Excipients qs Approved colour used. | IP | 10 mg |
| 227 | Paroxetine Hydrochloride Tablet | Each Film Coated Tablet Contains: Paroxetine Hydrochloride Eq. to Paroxetine Excipients qs Approved colour used. | IP | 20 mg |
| 228 | Paroxetine Hydrochloride Tablet | Each Film Coated Tablet Contains: Paroxetine Hydrochloride Eq. to Paroxetine Excipients qs Approved colour used. | IP | 30 mg |
| 229 | Paroxetine Hydrochloride Tablet | Each Film Coated Tablet Contains: Paroxetine Hydrochloride Eq. to Paroxetine Excipients qs Approved colour used. | IP | 40 mg |
| 230 | Dronedarone Hydrochloride Tablet | Each Film Coated Tablet Contains: Dronedarone Hydrochloride Eq. to Dronedarone Excipients qs Approved colour used. |
400 mg | |
| 231 | Canagliflozin Hemihydrate Tablet | Each Film Coated Tablet Contains: Canagliflozin Hemihydrate Eq. to Canagliflozin Excipients qs Approved colour used. |
100 mg | |
| 232 | Canagliflozin Hemihydrate Tablet | Each Film Coated Tablet Contains: Canagliflozin Hemihydrate Excipients qs Approved colour used. | 300 mg | |
| 233 | Eszopiclone Tablet | Each Film Coated Tablet Contains: Eszopiclone Excipients qs Approved colour used. | USP | 1 mg |
| 234 | Eszopiclone Tablet | Each Film Coated Tablet Contains: Eszopiclone Excipients qs Approved colour used. | USP | 2 mg |
| 235 | Eszopiclone Tablet | Each Film Coated Tablet Contains: Eszopiclone Excipients qs Approved colour used. | USP | 3 mg |
| 236 | Eslicarbazepine Acetate Tablet | Each Uncoated Tablet Contains: Eslicarbazepine Acetate Excipients qs Approved colour used. | IP | 200 mg |
| 237 | Eslicarbazepine Acetate Tablet | Each Uncoated Tablet Contains: Eslicarbazepine Acetate Excipients qs Approved colour used. | IP | 400 mg |
| 238 | Eslicarbazepine Acetate Tablet | Each Uncoated Tablet Contains: Eslicarbazepine Acetate Excipients qs Approved colour used. | IP | 600 mg |
| 239 | Eslicarbazepine Acetate Tablet | Each Uncoated Tablet Contains: Eslicarbazepine Acetate Excipients qs Approved colour used. | IP | 800 mg |
| 240 | Leflunomide Tablet | Each Film Coated Tablet Contains: Leflunomide Excipients qs Approved colour used. | IP | 10 mg |
| 241 | Leflunomide Tablet | Each Film Coated Tablet Contains: Leflunomide Excipients qs Approved colour used. | IP | 20 mg |
| 242 | Leflunomide Tablet | Each Film Coated Tablet Contains: Leflunomide Excipients qs Approved colour used. | IP | 100 mg |
| 243 | Mycophenolate Mofetil Tablet | Each Film Coated Tablet Contains: Mycophenolate Mofetil Excipients qs Approved colour used. | IP | 250 mg |
| 244 | Mycophenolate Mofetil Tablet | Each Film Coated Tablet Contains: Mycophenolate Mofetil Excipients qs Approved colour used. | IP | 500 mg |
| 245 | Azilsartan Medoxomil Tablet | Each Uncoated Tablet Contains: Azilsartan Kamedoxomil Eq. to Azilsartan Medoxomil Excipients qs Approved colour used. |
40 mg | |
| 246 | Azilsartan Medoxomil Tablet | Each Uncoated Tablet Contains: Azilsartan Kamedoxomil Eq. to Azilsartan Medoxomil Excipients qs Approved colour used. |
80 mg | |
| 247 | Faropenem Tablet | Each Film Coated Tablet Contains: Faropenem Sodium Eq. to Faropenem Excipients qs Approved colour used. | 200 mg | |
| 248 | Faropenem Sodium Tablet | Each Film Coated Tablet Contains: Faropenem Sodium Eq. to Faropenem Excipients qs Approved colour used. | 150 mg | |
| 249 | Faropenem Sodium Tablet | Each Film Coated Tablet Contains: Faropenem Sodium Eq. to Faropenem Excipients qs Approved colour used. | 200 mg | |
| 250 | Calcium Carbonate, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5-Phosphate Tablets | Each Film Coated Tablets Contains: Calcium Carbonate Eq. to Elemental Calcium Vitamin D3 Methylcobalamin L-Methylfolate Calcium Pyridoxal 5 Phosphate Excipients q.s Approved Colour Used. |
IP IP | 1250 mg 500 mg 2000 IU 1500 mcg 1 mg 20 mg |
| 251 | Tolperisone Hydrochloride & Diclofenac Sodium Tablet | Each Film Coated Tablet Contains: Tolperisone Hydrochloride Diclofenac Sodium Excipients q.s Approved Colour Used |
IP IP | 150 mg 50 mg |
| 252 | Ketorolac Tromethamine Dispersible Tablets | Each Uncoated DispersibleTablet Contains: Ketorolac Tromethamine Excipients q.s. Colour: Approved Colour | IP | 10 mg |
| 253 | Tranexamic Acid Tablets IP | Each Film Coated Tablet Contains: Tranexamic Acid Excipients q.s. Colour: Approved Colour | IP | 250 mg |
| 254 | Tranexamic Acid Tablets IP | Each Film Coated Tablet Contains: Tranexamic Acid Excipients q.s. Colour: Approved Colour | IP | 500 mg |
| 255 | Nortriptyline Hydrochloride & Pregabalin Tablet | Each Film Coated Tablet Contains: Pregabalin Nortriptyline Hydrochloride Eq. to Nortriptyline Excipients q.s. Colour: Approved Colour |
IP IP | 75 mg 10 mg |
| 256 | Levamisole Hydrochloride Tablets IP | Each Uncoated Tablet Contains: Levamisole Hydrochloride Eq. to Levamisole Excipients q.s. Colour: Approved Colour |
IP | 50 mg |
| 257 | Levamisole Hydrochloride Tablets IP | Each Uncoated Tablet Contains: Levamisole Hydrochloride Eq. to Levamisole Excipients q.s. Colour: Approved Colour |
IP | 150 mg |
| 258 | Cetirizine Hydrochloride Tablet IP | Each Film Coated Tablet Contains: Cetirizine Hydrochloride Excipients q.s. Colour: Approved Colour | IP | 10 mg |
| 259 | Cetirizine Hydrochloride Tablet IP | Each Film Coated Tablet Contains: Cetirizine Hydrochloride Excipients q.s. Colour: Approved Colour | IP | 20 mg |
| 260 | Pregabalin Sustained Release Tablet | Each Film Coated Tablet Contains Pregabalin (As Sustained Release) Excipients q.s. Colour: Approved Colour | IP | 75 mg |
| 261 | Cetirizine Hydrochloride Tablet IP | Each Film Coated Tablet Contains: Cetirizine Hydrochloride Excipients q.s. Colour: Approved Colour | IP | 5 mg |
| 262 | Furosemide and Spironolactone Tablet | Each Film Coated Tablet Contains : Furosemide Spironolactone Excipients q.s. Approved colour used | IP IP | 20 mg 50 mg |
| 263 | Piracetam Tablet | Each Film Coated Tablet Contains : Piracetam Excipients q.s. Approved colour used | IP | 400 mg |
| 264 | Piracetam Tablet | Each Film Coated Tablet Contains : Piracetam Excipients q.s. Approved colour used | IP | 800 mg |
| 265 | Ursodeoxycholic Acid Tablet IP | Each Film Coated Tablet Contains : Ursodeoxycholic Acid Excipients q.s. Approved colour used | IP | 150 mg |
| 266 | Sucralfate Tablet IP | Each Film Coated Tablet Contains : Sucralfate Excipients q.s. Approved colour used | IP | 1000 mg |
| 267 | Methylcobalamin, Alpha Lipoic Acid, Folic Acid, Thiamine & Pyridoxine Tablet | Each Film Coated Tablet Contains : Methylcobalamin Alpha Lipoic Acid Folic Acid Thiamine Mononitrate Pyridoxine Hydrochloride |
IP USP IP IP IP | 1500 mcg 100 mg 1.5 mg 10 mg 3 mg |
| 268 | L-Carnitine L-Tartrate, Ubidecarenone (Coenzyme Q10), Zinc Sulphate, Lycopene & Astaxanthin Tablet | Each Film Coated Tablet Contains : L-Carnitine L-Tartrate, Ubidecarenone (Coenzyme Q10) Zinc Sulphate Monohydrate Eq. to Elemental Zinc Lycopene (10%) Astaxanthin (10%) Excipients q.s. Approved colour used |
USP USP IP USP USP | 500 mg, 50 mg, 5 mg, 2500 mcg, 8 mg |
| 269 | Levocetirizine Hydrochloride, Montelukast Sodium & Ambroxol Hydrochloride (SR) Tablet | Each Uncoated Tablet Contains : Levocetirizine Hydrochloride Montelukast Sodium Eq. to Montelukast Ambroxol Hydrochloride (As Sustained Release) Excipients q.s. Approved colour used |
IP IP IP | 5 mg, 10 mg, 75 mg |
| 270 | Acebrophylline Capsules | Each Hard Gelatin Capsule Contains: Acebrophylline Excipients q.s. Approved colour used in Capsule Shell. | 100 mg | |
| 271 | Ferrous Bisglycinate, Zinc Bisglycinate, Folic Acid & Methylcobalamin Tablet | Each Film Coated Tablet Contains : Ferrous Bisglycinate Eq. to Elemental Iron Zinc Bisglycinate Eq. to Elemental Zinc Folic Acid Methylcobalamin Excipients q.s. Approved colour used |
IP IP | 60 mg, 15 mg, 1 mg, 500 mcg |
| 272 | Mirabegron Extended Release Tablet | Each Film Coated Extended Release Tablet Contains : Mirabegron Excipients q.s. Approved colour used | 25 mg | |
| 273 | Amlodipine Besylate, Olmesartan Medoxomil & Hydrochlorothiazide Tablet | Each Film Coated Tablet Contains : Amlodipine Besylate Eq. to Amlodipine Olmesartan Medoxomil Hydrochlorothiazide Excipients q.s. Approved colour used |
IP IP IP | 5 mg, 5 mg, 12.5 mg |
| 274 | Amlodipine Besylate, Olmesartan Medoxomil & Hydrochlorothiazide Tablet | Each Film Coated Tablet Contains : Amlodipine Besylate Eq. to Amlodipine Olmesartan Medoxomil Hydrochlorothiazide Excipients q.s. Approved colour used |
IP IP IP | 2.5 mg, 5 mg, 12.5 mg |
| 275 | Aciclovir Dispersible Tablets IP | Each Uncoated Dispersible Tablet Contains : Aciclovir Excipients q.s. Approved Colour used | IP | 400 mg |
| 276 | Naproxen Tablet IP | Each Film Coated Tablet Contains : Naproxen Excipients q.s. Approved Colour used | IP | 250 mg |
| 277 | Naproxen Tablet IP | Each Film Coated Tablet Contains : Naproxen Excipients q.s. Approved Colour used | IP | 500 mg |
| 278 | Mefenamic Acid & Paracetamol Tablet | Each film Coated Tablet Contains : Mefenamic Acid Paracetamol Excipients q.s. Approved Colour used | IP IP | 500 mg, 325 mg |
| 279 | Sodium Bicarbonate Tablets USP | Each Film Coated Tablet Contains: Sodium Bicarbonate Excipients q.s Approved colour used. | IP | 500 mg |
| 280 | Diclofenac Potassium and Paracetamol Tablets | Each Film Coated Tablet Contains: Diclofenac Potassium Paracetamol Excipients q.s | BP IP | 50 mg, 325 mg |
| 281 | Lansoprazole Orally Disintegrating Tablets | Each Uncoated Tablet Contains : Lansoprazole Excipients q.s. Approved Colour used | IP | 15 mg |
| 282 | Labetalol Hydrochloride Tablet IP | Each Film Coated Tablet Contains: Labetalol Hydrochloride Excipients q.s. Approved Colour used | IP | 50 mg |
| 283 | Labetalol Hydrochloride Tablet IP | Each Film Coated Tablet Contains: Labetalol Hydrochloride Excipients q.s. Approved Colour used | IP | 100 mg |
| 284 | Labetalol Hydrochloride Tablet IP | Each Film Coated Tablet Contains: Labetalol Hydrochloride Excipients q.s. Approved Colour used | IP | 200 mg |
| 285 | Labetalol Hydrochloride Tablet IP | Each Film Coated Tablet Contains: Labetalol Hydrochloride Excipients q.s. Approved Colour used | IP | 400 mg |
| 286 | Loratadine Orally Disintegrating Tablets | Each Uncoated Orally Disintegrating Tablet Contains: Loratadine Excipients q.s. Approved Colour used | USP | 10 mg |
| 287 | Artemether and Lumefantrine Dispersible Tablet | Each Uncoated Dispersible Tablet Contains: Artemether Lumefantrine Excipients q.s. Approved Colour used | IP | 80 mg, 480 mg |
| 288 | Paracetamol, Levocetirizine Hydrochloride, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & Caffeine Tablets |
Each Uncoated Tablet Contains: Paracetamol Levocetirizine Hydrochloride Dextromethorphan Hydrobromide Phenylephrine Hydrochloride CaffeineAnhydrous Excipients q.s. Approved Colour used |
IP IP IP IP IP | 325 mg, 5 mg, 5 mg, 5 mg, 30 mg |
| 289 | L–Ornithine L-Aspartate and Pancreatin Tablet | Each Enteric Coated Tablet Contains: L–Ornithine L-Aspartate Pancreatin Excipients q.s. Approved colours used | IP | 150 mg, 100 mg |
| 290 | Ferrous Ascorbate, Folic Acid & Zinc Sulphate Tablet | Each Film Coated Tablet Contains: Ferrous Ascorbate Folic Acid Zinc Sulphate Monohydrate Eq. to Elemental Zinc Excipients q.s. Approved colours used |
IP IP IP | 100 mg, 1.5 mg, 22.5 mg |
| 291 | Ferrous Bisglycinate, Folic Acid, Zinc Bisglycinate and Methylcobalamin Tablet | Each Film Coated Tablet Contains: Ferrous Bisglycinate Folic Acid Zinc Bisglycinate Methylcobalamin Excipients q.s. Approved colours used |
IP IP | 60 mg, 1 mg, 15 mg, 500 mcg |
| 292 | Nortriptyline HCl, Pregabalin and Methylcobalamin Tablet | Each Uncoated Bi-layered Tablet Contains: Nortriptyline Hydrochloride Pregabalin Methylcobalamin Excipients q.s. Approved colours used |
IP IP IP | 10 mg, 75 mg, 1500 mcg |
| 293 | Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Tablet | Each Uncoated Tablet Contains: Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride Chlorpheniramine Maleate Excipients q.s. Approved colours used |
IP IP IP | 10 mg, 5 mg, 2 mg |
| 294 | Flupentixol & Melitracen Tablet | Each Film Coated Tablet Contains: Flupentixol Hydrochloride Eq. to Flupentixol Melitracen Hydrochloride Eq. to Melitracen Excipients q.s. Approved colours used |
BP | 0.5 mg, 10 mg |
| 295 | Paracetamol & Caffeine Tablet IP | Each Uncoated Tablet Contains: Paracetamol Caffeine Anhydrous Excipients q.s. Approved Colour used | IP IP | 650 mg, 50 mg |
| 296 | Paracetamol & Caffeine Tablet IP | Each Uncoated Tablet Contains: Paracetamol Caffeine Anhydrous Excipients q.s. Approved Colour used | IP IP | 500 mg, 25 mg |
| 297 | Paracetamol & Caffeine Tablet | Each Uncoated Tablet Contains: Paracetamol Caffeine Anhydrous Excipients q.s. Approved Colour used | IP IP | 500 mg, 50 mg |
| 298 | Paracetamol & Caffeine Tablet | Each Uncoated Tablet Contains: Paracetamol Caffeine Anhydrous Excipients q.s. Approved Colour used | IP IP | 250 mg, 25 mg |
| 300 | Etodolac and Thiocolchicoside Tablet | Each Film coated Tablet Contains : Etodolac Thiocolchicoside Excipients q.s Approved colour used. | IP IP | 300 mg, 4 mg |
| 301 | Rosuvastatin Calcium and Fenofibrate Tablet | Each Film Coated Tablet Contains : Rosuvastatin Calcium Eq. to Rosuvastatin Fenofibrate (Micronised) Excipients q.s Approved colour used |
IP IP | 20 mg, 160 mg |
| 302 | Atorvastatin Calcium and Fenofibrate Tablet | Each Film Coated Tablet Contains : Atorvastatin Calcium Eq. to Atorvastatin Fenofibrate Fenofibrate (Micronised) Excipients q.s Approved colour used |
IP IP | 10 mg, 160 mg |
| 303 | Nitrofurantoin Sustained Release Tablet | Each Film Coated Sustained Release Tablet Contains : Nitrofurantoin Excipients q.s Approved colour used | IP | 100 mg |
| 304 | Rifaximin Tablet | Each Film Coated Tablet Contains : Rifaximin Excipients q.s Approved colour used | 550 mg | |
| 305 | Vildagliptin & Metformin HCL Tablet | Each Film Coated Tablet Contains : Vildagliptin Metformin Hydrochloride Excipients q.s Approved colour used | IP | 50 mg, 500 mg |
| 306 | Naproxen Sodium & Domperidone Tablet | Each Film Coated Tablet Contains : Domperidone Maleate Eq. to Domperidone Naproxen Sodium Excipients q.s Approved colour used |
IP BP | 10 mg, 500 mg |
| 307 | Levofloxacin & Ornidazole Tablets | Each Film Coated Tablet Contains: Levofloxacin Hemihydrate Eq. to Levofloxacin Ornidazole Excipients q.s Approved colour used |
IP IP | 250 mg, 500 mg |
| 308 | Nimesulide, Cetirizine, Phenylephrine and Caffeine Tablets | Each Uncoated Tablet contains: Nimesulide Cetirizine Dihydrochloride Phenylephrine Hydrochloride Caffeine (Anhydrous) Excipients q.s Approved colour used |
BP IP IP IP | 100 mg, 5 mg, 10 mg, 30 mg |
| 309 | Gabapentin and Nortriptyline Hydrochloide Tablets | Each Film Coated Tablet Contains: Gabapentin Nortriptyline Hydrochloride Eq. to Nortriptyline Excipients q.s Approved colour used. |
IP IP | 100 mg, 10 mg |
| 310 | Atorvastatin Calcium and Fenofibrate Tablet | Each Film Coated Tablet Contains : Atorvastatin Calcium Eq. to Atorvastatin Fenofibrate Fenofibrate (Micronised) Excipients q.s Approved colour used |
IP IP | 20 mg, 160 mg |
| 311 | Nimesulide, Paracetamol & Serratiopeptidase Tablet | Each Film Coated Tablet Contains: Nimesulide Paracetamol Serratiopeptidase Excipients q.s. Approved Colour used | BP IP IP | 100 mg, 325 mg, 10 mg |
| 312 | Diclofenac Potassium & Paracetamol Tablet | Each Uncoated Bilayered Tablet Contains: Diclofenac Potassium Paracetamol Excipients q.s. Approved Colour used | BP IP | 50 mg, 325 mg |
| 313 | Nimesulide & Paracetamol Tablet | Each Uncoated Bi-layered Tablet Contains: Nimesulide Paracetamol Excipients q.s. Approved Colour used | BP IP | 100 mg, 325 mg |
| 314 | Flupirtine Maleate & Paracetamol Tablet | Each Uncoated bi-layered Tablet Contains: Flupirtine Maleate Paracetamol Excipients q.s Approved colour used. | IP | 100 mg, 325 mg |
| 315 | Doxofylline (SR) and Montelukast Sodium Tablet | Each Film Coated Tablet Contains: Doxofylline (In Sustained Release Form) Montelukast Sodium Eq. to Montelukast Excipients q.s. Approved colours used |
IP IP | 400 mg, 10 mg |
| 316 | Deflazacort Tablets | Each Uncoated Tablet Contains: Deflazacort Excipients q.s | 12 mg | |
| 317 | Thiocolchicoside & Aceclofenac Tablets | Each Film Coated Tablet Contains: Thiocolchicoside Aceclofenac Excipients q.s. Approved Colour used | IP IP | 4 mg, 100 mg |
| 318 | Gabapentin and Methylcobalamin Tablets | Each Film Coated Tablet Contains: Gabapentin Methylcoabalamin Excipients q.s Approved colour used. | IP IP | 300 mg, 500 mcg |
| 319 | Rosuvastatin and Fenofibrate Tablet | Each Film Coated Tablet Contains: Rosuvastatin Calcium Eq. to Rosuvastatin Fenofibrate Excipients q.s Approved colour used |
IP IP | 10 mg, 160 mg |
| 320 | Levocetirizine Dihydrochloride and Ambroxol Hydrochloride Tablet | Each Film Coated Tablet Contains: Levocetirizine Dihydrochloride Ambroxol Hydrochloride Excipients q.s Approved colour used |
IP IP | 5 mg, 60 mg |
| 321 | Deflazacort Tablets | Each Uncoated Tablet Contains: Deflazacort Excipients q.s | 6 mg | |
| 322 | Etodolac ER Tablet IP | Each Film Coated Extended Release Tablet Contains: Etodolac Excipients q.s Approved colour used | IP | 200 mg |
| 323 | Etodolac ER Tablet IP | Each Film Coated Extended Release Tablet Contains: Etodolac Excipients q.s Approved colour used | IP | 600 mg |
| 324 | Ciprofloxacin Tablets IP | Each Film Coated Tablet Contains: Ciprofloxacin Hydrochloride Eq. to Ciprofloxacin Excipients q.s Approved colour used. |
IP | 250 mg |
| 325 | Ciprofloxacin Tablets IP | Each Film Coated Tablet Contains: Ciprofloxacin Hydrochloride Eq. to Ciprofloxacin Excipients q.s Approved colour used. |
IP | 500 mg |
| 326 | Ciprofloxacin Tablets IP | Each Film Coated Tablet Contains: Ciprofloxacin Hydrochloride Eq. to Ciprofloxacin Excipients q.s Approved colour used. |
IP | 750 mg |
| 327 | Ondansetron Orally Disintegrating Tablets IP | Each Orally Disintegrating Uncoated Tablet Contains: Ondansetron Hydrochloride Eq. to Ondansetron Excipients q.s | IP | 4 mg |
| 328 | Ondansetron Orally Disintegrating Tablets IP | Each Orally Disintegrating Uncoated Tablet Contains: Ondansetron Hydrochloride Eq. to Ondansetron Excipients q.s | IP | 8 mg |
| 329 | Diclofenac Potassium and Paracetamol Tablets | Each Uncoated Tablet Contains: Diclofenac Potassium Paracetamol Excipients q.s | BP IP | 50 mg, 325 mg |
| 330 | Paracetamol, Phenylephrine HCL, Caffeine and Diphenhydramine HCl Tablets | Each Uncoated Tablet Contains: Paracetamol Phenylephrine Hydrochloride Caffeine (Anhydrous) Diphenhydramine HCl Excipients q.s |
IP IP IP IP | 500 mg, 5 mg, 30 mg, 25 mg |
| 331 | Paracetamol, Cetirizine HCl & Phenylephrine HCL, Tablets. | Each Uncoated Tablet Contains: Paracetamol Phenylephrine Dihydrochloride Cetirizine Hydrochloride Excipients q.s | IP IP IP | 325 mg, 5 mg, 5 mg |
| 332 | Telmisartan & Amlodipine Tablet IP | Each Uncoated Tablet Contains: Telmisartan Amlodipine Besylate Eq. to Amlodipine Excipients q.s | IP IP | 40 mg, 5 mg |
| 333 | Nimesulide, Paracetamol & Chlorzoxazone Tablet | Each Film Coated Tablet Contains: Nimesulide Paracetamol Chlorzoxazone Excipients q.s Approved Colour Used | BP IP USP | 100 mg, 325 mg, 250 mg |
| 334 | Paracetamol, Phenylephrine Hydrochloride & Caffeine Tablet | Each Uncoated Tablet Contains: Paracetamol Phenylephrine Hydrochloride Caffeine (Anhydrous) Excipients q.s | IP IP IP | 500 mg, 5 mg, 30 mg |
| 335 | Nimesulide, Paracetamol, Phenylephrine Hydrochloride & Caffeine Tablets | Each Uncoated Bilayered Tablet Contains: Nimesulide Paracetamol Phenylephrine Hydrochloride Caffeine (Anhydrous) Excipients q.s Approved Colour Used |
BP IP IP IP | 100 mg, 325 mg, 10 mg, 25 mg |
| 336 | Diacerein, Glucosamine Sulphate Potassium Chloride and Methyl Sulfonyl Methane Tablets | Each Film Coated Tablet Contains: Diacerein Glucosamine Sulphate Potassium Chloride Methyl Sulfonyl Methane Excipients q.s Approved colour used |
IP USP USP | 50 mg, 750 mg, 250 mg |
| 337 | Moxifloxacin Hydrochloride Tablet | Each Film Coated Tablet Contains: Moxifloxacin Hydrochloride Eq. to Moxifloxacin Excipients q.s Approved Colour Used |
IP | 400 mg |
| 338 | Nimesulide, Paracetamol & Serratiopeptidase Tablet | Each Film Coated Tablet Contains: Nimesulide Paracetamol Serratiopeptidase Excipients q.s. Approved Colour used | BP IP IP | 100 mg, 325 mg, 15 mg |
| 339 | Paracetamol, Phenylephrine HCL & Cetirizine Tablets | Each Uncoated Tablet Contains: Cetirizine Dihydrochloride Phenylephrine Hydrochloride Paracetamol Excipients q.s. Approved Colour used |
IP IP IP | 5 mg, 5 mg, 500 mg |
| 340 | Montelukast Sodium & Fexofenadine HCL Tablet | Each Film Coated Tablet Contains: Montelukast Sodium Eq. to Montelukast Fexofenadine Hydrochloride Excipients q.s Approved Colour Used |
IP IP | 10 mg, 120 mg |
| 341 | Nimesulide Tablet | Each Uncoated Tablet Contains: Nimesulide Excipients q.s | BP | 100 mg |
| 342 | Levocetirizine Hydrochloride & Montelukast Tablets | Each Uncoated Bilayered Tablet Contains: Levocetirizine Dihydrochloride Montelukast Sodium Eq. to Montelukast Excipients q.s Approved Colour Used |
IP IP | 5 mg, 10 mg |
| 343 | Paracetamol Tablets IP | Each Uncoated Tablet Contains: Paracetamol Excipients q.s Approved colour used. | IP | 650 mg |
| 344 | Pregabalin (SR), Nortriptyline & Methylcobalamin Tablet | Each Film Coated Tablet Contains : Pregabalin (As Sustained Release Form) Nortriptyline Hydrochloride Eq. to Nortriptyline Methylcobalamin Excipients q.s. Approved colour used |
IP IP IP | 75 mg, 10 mg, 1500 mcg |
| 345 | Albendazole and Ivermectin Tablets | Each Uncoated Chewable Tablet Contains: Albendazole Ivermectin Excipients q.s Approved colour used. | IP IP | 400 mg, 6 mg |
| 346 | Methylcobalamin Tablet | Each Uncoated Sublingual Tablet Contains: Methylcobalamin Excipients q.s Approved Colours Used | IP | 1500 mcg |
| 347 | Alfuzosin Prolonged- Release Tablet IP | Each Film Coated Prolonged-Release Tablet Contains: Alfuzosin Hydrochloride Excipients q.s Approved Colours Used | IP | 10 mg |
| 348 | Pregabalin (SR) and Methylcobalamin Tablet | Each Uncoated bilayered Tablet Contains: Pregabalin (As Sustained Release Form) Methylcobalamin Excipients qs Approved colour used. |
IP IP | 75 mg 1500 mcg |
| 349 | Pregabalin (SR) and Methylcobalamin Tablet | Each Uncoated bilayered Tablet Contains: Pregabalin (As Sustained Release Form) Methylcobalamin Excipients qs Approved colour used. |
IP IP | 150 mg 1500 mcg |
| 350 | Pregabalin (SR) and Methylcobalamin Tablet | Each Uncoated bilayered Tablet Contains: Pregabalin (As Sustained Release Form) Methylcobalamin Excipients qs Approved colour used. |
IP IP | 300 mg 1500 mcg |
| 351 | Norfloxacin & Tinidazole Tablet | Each Film Coated Tablet Contains: Norfloxacin Tinidazole Excipients q.s Approved Colours Used |
IP IP | 400 mg 600 mg |
| 352 | Piroxicam Sublingual Tablets | Each Uncoated Sublingual Tablet Contains: Piroxicam Excipients q.s Approved Colours Used |
IP | 20 mg |
| 353 | Flavoxate Tablets | Each Film Coated Tablet Contains: Flavoxate Hydrochloride Excipients q.s Approved Colours Used |
IP | 200 mg |
| 354 | Nitazoxanide & Ofloxacin Tablets | Each Film Coated Tablet Contains: Nitazoxanide Ofloxacin Excipients q.s Approved Colours Used |
IP | 500 mg 200 mg |
| 355 | Acebrophylline Sustained Release Tablets | Each Uncoated Sustained Release Tablet Contains: Acebrophylline Excipients q.s Approved Colours Used |
200 mg | |
| 356 | Linagliptin & Metformin Tablets | Each Film Coated Tablet Contains: Linagliptin Metformin Hydrochloride Excipients q.s Approved Colours Used |
IP | 2.5 mg 500 mg |
| 357 | Linagliptin & Metformin Tablets | Each Film Coated Tablet Contains: Linagliptin Metformin Hydrochloride Excipients q.s Approved Colours Used |
IP | 2.5 mg 1000 mg |
| 358 | Gabapentin, Methylcobalamin & Alpha Lipoic Acid Tablets | Each Film Coated Tablet Contains: Gabapentin Methylcobalamin Alpha Lipoic Acid Excipients q.s Approved Colours Used |
IP IP USP | 100 mg 0.50 mg 100 mg |
| 359 | Trypsin, Bromelain, Rutoside Trihydrate & Papain Tablets | Each Enteric Coated Tablet Contains: Trypsin Bromelain Rutoside Trihydrate Papain Excipients q.s Approved Colours Used |
BP BP IP | 48 mg 90 mg 100 mg 60 mg |
| 360 | Myo-Inositol & Metformin Hydrochloride Tablets | Each Film Coated Bilayered Tablet Contains: Myo-Inositol Metformin Hydrochloride (As Sustained Release Form) Excipients q.s Approved Colours Used |
BP IP | 600 mg 500 mg |
| 361 | Gabapentin, Nortriptyline Hydrochloride & Methylcobalamin Tablets | Each Film Coated Tablet Contains: Gabapentin Nortriptyline Hydrochloride Eq. to Nortriptyline Methylcobalamin Excipients q.s Approved colour used. |
IP IP IP | 100 mg 10 mg 1500 mcg |
| 362 | Pregabalin & Nortriptyline Hydrochloride Tablets | Each Film Coated Tablet Contains: Pregabalin Nortriptyline Hydrochloride Eq. to Nortriptyline Excipients q.s Approved colour used. |
IP IP | 50 mg 10 mg |
| 363 | Terbutaline Sulphate, Ambroxol Hydrochloride & Guaiphenesin Tablets | Each Uncoated Tablet Contains: Terbutaline Sulphate Ambroxol Hydrochloride Guaiphenesin Excipients q.s Approved colour used. |
IP IP IP | 2.5 mg 30 mg 100 mg |
| 364 | Erythromycin Tablets USP | Each Film Coated Tablet Contains: Erythromycin Stearate Eq. to Erythromycin Excipients q.s Approved colour used. |
IP | 500 mg |
| 365 | Camylofin & Paracetamol Tablets | Each Film Coated Tablet Contains: Camylofin Dihydrochloride Paracetamol Excipients q.s Approved colour used. |
IP | 25 mg 325 mg |
| 366 | Aceclofenac (SR) & Pregabalin (SR) Tablets | Each Film Coated Bilayered Tablet Contaons: Aceclofenac (As Sustained Release Form) Pregabalin (As Sustained Release Form) Excipients q.s Approved colour used. | IP IP | 200 mg 75 mg |
| 367 | Sodium Feredetate, Folic Acid & Vitamin B12 Tablets | Each Film Coated Tablet Contains: Sodium Feredetate Eq. to Elemental Iron Folic Acid Vitamin B12 Excipients q.s Approved colour used. | BP IP IP | 231 mg 33 mg 1.5 mg 15 mcg |
| 368 | Ondansetron and Omeprazole Tablets | Each Enteric Coated Tablet Contains: Ondansetron Hydrochloride Eq. to Ondansetron Omeprazole Excipients q.s Approved colour used. | IP IP | 4 mg 10 mg |
| 369 | Pregabalin Sustained Release and Etoricoxib Tablets | Each Uncoated Bilayered Tablet Contains: Pregabalin (As Sustained Release Form) Etoricoxib Excipients q.s Approved colour used. | IP IP | 75 mg 60 mg |
| 370 | Glimepiride, Voglibose and Metformin (SR) Tablets | Each uncoated bilayered Tablet contains: Glimepiride Voglibose Metformin Hydrochloride (In Sustained Release Form) Excipients q.s In Flavored Base Approved colour used. | IP IP IP | 1 mg 0.2 mg 500 mg |
| 371 | Glimepiride, Voglibose and Metformin (SR) Tablets | Each uncoated bilayered Tablet contains: Glimepiride Voglibose Metformin Hydrochloride (In Sustained Release Form) Excipients q.s In Flavored Base Approved colour used. | IP IP IP | 1 mg 0.3 mg 500 mg |
| 372 | Glimepiride, Voglibose and Metformin (SR) Tablets | Each uncoated bilayered Tablet contains: Glimepiride Voglibose Metformin Hydrochloride (In Sustained Release Form) Excipients q.s In Flavored Base Approved colour used. | IP IP IP | 2 mg 0.3 mg 500 mg |
| 373 | Ondansetron and Pantoprazole Tablets | Each Enteric Coated Tablet Contains: Pantoprazole Sodium Eq. to Pantoprazole Ondansetron Hydrochloride Excipients q.s Approved colour used. | IP IP | 40 mg 4 mg |
| 374 | Myo-Inositol & Metformin Hydrochloride Sustained Release Tablets | Each Uncoated Bilayered Tablet Contains: Myo-Inositol Metformin Hydrochloride (As Sustained Release Form) Excipients q.s Approved Colours Used | IP IP | 600 mg 500 mg |
| 375 | Teneligliptin Hydrobromide Hydrate and Metformin Hydrochloride Extended Release Tablet | Each Film Coated Tablet Contains: Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin Metformin Hydrochloride (In Extended Release Form) Excipients q.s Approved Colours Used | IP IP | 20 mg 500 mg |
| 376 | Teneligliptin Hydrobromide Hydrate and Metformin Hydrochloride Extended Release Tablet | Each Film Coated Tablet Contains: Teneligliptin Hydrobromide Hydrate Eq. to Teneligliptin Metformin Hydrochloride (In Extended Release Form) Excipients q.s Approved Colours Used | IP IP | 20 mg 1000 mg |
| 377 | Betahistine Dihydrochloride (SR) Tablet | Each Uncoated Tablet Contains: Betahistine Dihydrochloride (As Sustained Release Form) Excipients q.s Approved Colours Used | IP | 24 mg |
| 378 | Roxithromycin Tablets IP | Each Film Coated Tablet Contains: Roxithromycin Excipients q.s Approved colour used. | IP | 150 mg |
| 379 | Aceclofenac (SR) & Rabeprazole (EC) Capsules | Each Hard Gelatin Capsule Contains: Rabeprazole Sodium (as Enteric Coated Pellets) Aceclofenac (Sustained Release Pellets) Excipients q.s Approved colour used in empty capsule shell. | IP IP | 10 mg 200 mg |
| 380 | Aceclofenac (SR) & Rabeprazole (EC) Capsules | Each Hard Gelatin Capsule Contains: Rabeprazole Sodium (as Enteric Coated Pellets) Aceclofenac (Sustained Release Pellets) Excipients q.s Approved colour used in empty capsule shell. | IP IP | 20 mg 200 mg |
| 381 | Alfuzosin Tablet IP | Each Film Coated Tablet Contains: Alfuzosin Hydrochloride Excipients q.s Approved Colours Used |
IP | 10 mg |
| 382 | Cilnidipine, Telmisartam & Chlorthalidone Tablets | Each Film Coated Tablet Contains: Cilnidipine Telmisartan Chlorthalidone Excipients q.s Approved Colours Used |
IP IP IP | 10 mg 40 mg 6.25 mg |
| 383 | Paracetamol, Phenylephrine Hydrochloride & Levocetirizine Hydrochloride Tablet | Each Film Coated Tablet Contains: Paracetamol Phenylephrine Hydrochloride Levocetirizine Hydrochloride Excipients q.s Approved Colour Used |
IP IP IP | 325 mg 5 mg 5 mg |
| 384 | Nimesulide, Cetirizine, Phenylephrine and Caffeine Tablet | Each Uncoated Bilayered Tablet Contains: Nimesulide Cetirizine Dihydrochloride Phenylephrine Hydrochloride Caffeine (Anhydrous) Excipients q.s Approved Colour Used |
BP IP IP IP | 100 mg 5 mg 10 mg 30 mg |
| 385 | Ursodeoxycholic Acid Tablet | Each Uncoated Tablet Contains: Ursodeoxycholic Acid Excipients q.s | IP | 450 mg |
| 386 | Cilnidipine Tablet IP | Each Film Coated Tablet Contains: Cilnidipine Excipients q.s Approved Colours Used |
IP | 10 mg |
| 387 | Metformin (ER) & Gliclazide (M.R.) Tablets | Each Uncoated Bilayered Tablet Contains: Metformin Hydrochloride (As Extended Release form) Gliclazide (As Modified Release form) Excipients q.s Approved Colours Used |
IP IP | 500 mg 30 mg |
| 388 | Baclofen Tablet IP | Each Uncoated Tablet Contains: Baclofen Excipients q.s Approved Colours Used |
IP | 10 mg |
| 389 | Baclofen Tablet IP | Each Uncoated Tablet Contains: Baclofen Excipients q.s Approved Colours Used |
IP | 25 mg |
| 390 | Baclofen Tablet IP | Each Uncoated Tablet Contains: Baclofen Excipients q.s Approved Colours Used |
IP | 20 mg |
| 391 | Trypsin & Chymotrypsin Tablets | Each Enteric Coated Tablet Contains: 1,00,000 armour units of enzymatic activity supplied by a purified concentrate which has specific trypsin and chymotrypsin activity in a ratio of approximately six to one Approved colour used. Excipients q.s. |
1,00,000 AU | |
| 392 | Trypsin & Chymotrypsin Tablets | Each Enteric Coated Tablet Contains: 2,00,000 armour units of enzymatic activity supplied by a purified concentrate which has specific trypsin and chymotrypsin activity in a ratio of approximately six to one Approved colour used. Excipients q.s. |
2,00,000 AU | |
| 393 | Etodolac ER Tablet | Each Film Coated Extended Release Tablet Contains: Etodolac Excipients q.s Approved Colours Used |
IP | 400 mg |
| 394 | Metaxalone & Diclofenac Potassium Tablet | Each Film Coated Tablet Contains: Metaxalone Diclofenac Potassium Excipients q.s Approved Colours Used |
USP BP | 400 mg 50 mg |
| 395 | Tolperisone Hydrochloride Tablet | Each Film Coated Tablet Contains: Tolperisone Hydrochloride Excipients q.s Approved Colours Used |
IP | 150 mg |
| 396 | L-Carnitine L-Tartrate, Methylcobalamin & Folic Acid Tablet | Each Film Coated Tablet Contains: L-Carnitine L-Tartrate Eq. to L-Carnitine Methylcobalamin Folic Acid Excipients q.s Approved Colours Used |
USP IP IP |
500 mg 1500 mcg 1.5 mg |
| 397 | Rifaximin Tablet | Each Film Coated Tablet Contains : Rifaximin Excipients q.s Approved colour used |
400 mg | |
| 398 | Drotaverine HCl and Aceclofenac Tablets | Each Film Coated Tablet Contains: Drotaverine Hydrochloride Eq. to Drotaverine Aceclofenac Excipients q.s Approved colour used. |
IP IP | 80 mg 100 mg |
| 399 | Thiocolchicoside & Aceclofenac Tablets | Each Film Coated Tablet Contains: Thiocolchicoside Aceclofenac Excipients q.s. Approved Colour used |
IP IP | 8 mg 100 mg |
| 400 | Bilastine & Montelukast Sodium Tablets | Each Film Coated Tablet Contains: Bilastine Montelukast Sodium Eq. to Montelukast Excipients q.s Approved Colour Used |
IP | 20 mg 10 mg |
| 401 | Metformin HCl and Gliclazide Tablets | Each Uncoated Bilayered Tablet Contains: Metformin Hydrochloride Gliclazide Excipients q.s Approved colour used. |
IP IP | 500 mg 80 mg |
| 402 | Paracetamol,Phenylephrine HCl, Caffeine and Diphenhydramine HCl Tablets | Each Film Coated Tablet Contains: Paracetamol Phenylephrine Hydrochloride Caffeine (Anhydrous) Diphenhydramine Hydrochloride Excipients q.s Approved colour used. |
IP IP IP IP | 325 mg 5 mg 30 mg 25 mg |
| 403 | Rifaximin Tablet | Each Film Coated Tablet Contains : Rifaximin Excipients q.s Approved colour used |
200 mg | |
| 404 | Betahistine Tablet | Each Uncoated Tablet contains : Betahistine Hydrochloride Excipients q.s | IP | 24 mg |
| 405 | Esomeprazole Tablets IP | Each Enteric Coated Tablet Contains: Esomeprazole Magnesium Trihydrate Eq. to Esomeprazole Excipients q.s Approved colour used |
IP | 40 mg |
| 406 | Etoricoxib Tablets IP | Each Film Coated Tablet contains : Etoricoxib Excipients q.s Approved colour used | IP | 60 mg |
| 407 | Paracetamol Sustained Release Tablets | Each Uncoated Bilayered Tablet Contains : Paracetamol (As Immediate Release) Paracetamol (As Sustained Release) Excipients q.s Approved colour used. |
IP IP | 300 mg 700 mg |
| 408 | Telmisartan and Amlodipine Tablet IP | Each Uncoated Bilayered tablet contains : Telmisartan Amlodipine Besylate Eq. to Amlodipine Excipients q.s. Approved colour used |
IP IP | 80 mg 5 mg |
| 409 | Dapagliflozin Tablet | Each Film Coated Tablet contains : Dapagliflozin Propanediol Monohydrate Eq. to Dapagliflozin Excipients q.s Approved colour used |
10 mg | |
| 410 | Naproxen Sodium & Domperidone Tablet | Each Film Coated Tablet Contains : Domperidone Maleate Eq. to Domperidone Naproxen Sodium Excipients q.s Approved colour used |
IP USP | 10 mg 250 mg |
| 411 | Etoricoxib & Paracetamol Tablets | Each Film Coated Tablet contains : Etoricoxib Paracetamol Excipients q.s Approved colour used | IP IP | 60 mg 325 mg |
| 412 | Etodolac and Thiocolchicoside Tablet | Each Film Coated Tablet Contains : Etodolac Thiocolchicoside Excipients q.s Approved colour used. | IP IP | 400 mg 8 mg |
| 413 | Telmisartan Tablet IP | Each Uncoated Tablet Contains: Telmisartan Excipients q.s | IP | 20 mg |
| 414 | Acotiamide Hydrochloride Sustained Release Tablets | Each Film Coated Sustained Release Tablet Contains: Acotiamide Hydrochloride Hydrate (As Sustained Release) Excipients q.s Approved colour used. |
100 mg | |
| 415 | Paroxetine Hydrochloride Prolonged- Release Tablet IP | Each Film Coated Prolonged-Release Tablet Contains: Paroxetine Hydrochloride Eq. to Paroxetine Excipients q.s Approved colour used . |
IP | 12.5 mg |
| 416 | Allopurinol Tablet IP | Each Uncoated Tablet contains : Allopurinol Excipients q.s Approved colour used | IP | 100 mg |
| 417 | Allopurinol Tablet IP | Each Uncoated Tablet contains : Allopurinol Excipients q.s Approved colour used | IP | 300 mg |
| 418 | Erythromycin Stearate Tablets IP | Each Film Coated Tablet Contains: Erythromycin Stearate Eq. to Erythromycin Excipients q.s Approved colour used. | IP | 250 mg |
| 419 | Hydroxychloroquine Tablets IP | Each Film Coated Tablet contains : Hydroxychloroquine Sulphate Excipients q.s Approved colour used | IP | 200 mg |
| 420 | Aceclofenac and Paracetamol Tablet IP | Each Film Coated Tablet Contains: Aceclofenac Paracetamol Approved Colour used Excipients q.s | IP IP | 100 mg 325 mg |
| 421 | Telmisartan & Hydrochlorothiazide Tablet IP | Each Uncoated Tablet Contains: Telmisartan Hydrochlorothiazide Excipients q.s | IP IP | 40 mg 12.5 mg |
| 422 | Telmisartan & Hydrochlorothiazide Tablet | Each Uncoated Bilayered Tablet Contains: Telmisartan Hydrochlorothiazide Excipients q.s Approved colour used. | IP IP | 40 mg 12.5 mg |
| 423 | Atorvastatin Tablets IP | Each Film Coated Tablet Contains : Atorvastatin Calcium Eq. to Atorvastatin Excipients q.s Approved colour used | IP | 20 mg |
| 424 | Paracetamol, Phenylephrine Hydrochloride, Guaiphenesin, Cetirizine Dihydrochloride and Ambroxol Hydrochloride Tablet |
Each Uncoated Tablet Contains : Paracetamol Phenylephrine Hydrochloride Guaiphenesin Cetirizine Dihydrochloride Ambroxol Hydrochloride Excipients qs |
IP IP IP IP IP | 325 mg 5 mg 50 mg 5 mg 15 mg |
| 425 | Azithromycin Tablets IP | Each Film Coated Tablet Contains: Azithromycin Dihydrate Eq. to Azithromycin (Anhydrous) Excipients q.s Approved colour used. |
IP | 500 mg |
| 426 | Rabeprazole Sodium with Domperidone Gastro-resistant Tablets | Each Gastro-resistant tablet Contains: Rabeprazole Sodium Domperidone Approved Colour used Excipients q.s | IP IP | 20 mg 10 mg |
| 427 | Glimepiride, Voglibose and Metformin (SR) Tablets | Each uncoated bilayered Tablet Contains: Metformin Hydrochloride (In Sustained Release Form) Glimepiride Voglibose Excipients q.s In Flavored Base Approved colour used. |
IP IP IP | 500 mg 2 mg 0.2 mg |
| 428 | Clarithromycin Tablets IP | Each Film Coated Tablet Contains: Clarithromycin Excipients q.s Approved colour used. | IP | 250 mg |
| 429 | Clarithromycin Tablets IP | Each Film Coated Tablet Contains: Clarithromycin Excipients q.s Approved colour used. | IP | 500 mg |
| 430 | Paracetamol, Diclofenac Potassium and Serratiopeptidase Tablets. | Each Film Coated Tablet Contains: Paracetamol Diclofenac Potassium Serratiopeptidase (As enteric coated granules) Eq. to 30,000 Enzymatic units of Serratiopeptidase) Excipients q.s Approved colour used. |
IP BP IP | 325 mg 50 mg 15 mg |
| 431 | Myo-Inositol & Metformin Hydrochloride Sustained Release Tablets | Each Uncoated Tablet Contains: Myo-Inositol Metformin Hydrochloride (As Sustained Release Form) Excipients q.s Approved Colours Used |
IP IP | 600 mg 500 mg |
| 432 | Vildagliptin Tablet IP | Each Uncoated Tablet Contains: Vildagliptin Excipients q.s | IP | 50 mg |
| 433 | Empagliflozin Tablets | Each Film Coated Tablet Contains: Empagliflozin Excipients q.s Approved Colours Used | 10 mg | |
| 434 | Empagliflozin and Linagliptin Tablets | Each Film Coated Tablet Contains: Empagliflozin Linagliptin Excipients q.s Approved Colours Used | 10 mg 5 mg | |
| 435 | Empagliflozin and Linagliptin Tablets | Each Film Coated Tablet Contains: Empagliflozin Linagliptin Excipients q.s Approved Colours Used | 25 mg 5 mg | |
| 436 | Empagliflozin and Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: Empagliflozin Metformin Hydrochloride Excipients q.s Approved Colours Used | IP | 5 mg 500 mg |
| 437 | Empagliflozin and Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: Empagliflozin Metformin Hydrochloride Excipients q.s Approved Colours Used | IP | 12.5 mg 500 mg |
| 438 | Telmisartan & Metoprolol Succinate (Sustained-release) Tablet | Each Uncoated Bilayered Tablet Contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Sustained-release Form) Telmisartan Excipients q.s Approved colour used. |
IP IP | 47.50 mg 50 mg 40 mg |
| 439 | Aceclofenac and Paracetamol Tablet IP | Each Uncoated Tablet Contains: Aceclofenac Paracetamol Excipients q.s | IP IP | 100 mg 325 mg |
| 440 | Chlorthalidone Tablet | Each Uncoated Tablet Contains: Chlorthalidone Excipients q.s | IP | 6.25 mg |
| 441 | Doxofylline & Ambroxol Hydrochloride Tablet | Each Film Coated Tablet Contains: Doxofylline Ambroxol Hydrochloride Approved Colours Used Excipients q.s | IP IP | 400 mg 30 mg |
| 442 | Empagliflozin Tablets | Each Film Coated Tablet Contains: Empagliflozin Excipients q.s Approved Colours Used | 25 mg | |
| 443 | Drotaverine Hydrochloride Tablets IP | Each Film Coated Tablet Contains : Drotaverine Hydrochloride Eq. to Drotaverine Approved colour used Excipients q.s |
IP | 80 mg |
| 445 | Aceclofenac and Serratiopeptidase Tablets | Each Film Coated Tablet Contains: Aceclofenac Serratiopeptidase (As enteric coated granules) Eq. to 30,000 Enzymatic units of Serratiopeptidase) Excipients q.s Approved colour used. |
IP IP | 100 mg 15 mg |
| 446 | Aceclofenac, Paracetamol, Cetirizine Hydrochloride, Phenylephrine HCL & Caffeine Tablet. | Each Uncoated tablet Contains : Aceclofenac Paracetamol Cetirizine Hydrochloride Phenylephrine Hydrochloride Caffeine(Anhydrous) Excipients q.s. Approved colour used |
IP IP IP IP IP | 100 mg 325 mg 10 mg 5 mg 25 mg |
| 447 | Levocetirizine Dihydrochloride Dispersible Tablet | Each Uncoated Dispersible Tablet contains : Levocetirizine Dihydrochloride Excipients qs | IP | 10 mg |
| 448 | Calcitriol, Calcium Citrate and Zinc Sulphate Tablet | Each Film coated Tablet Contains : Calcitriol Calcium Citrate Zinc Sulphate Monohydrate Eq. to Elemental Zinc Excipients qs |
IP USP IP | 0.25 mcg 1000 mg 7.5 mg |
| 449 | Mefenamic Acid and Dicyclomine Hydrochloride Tablet. IP | Each Uncoated Tablet contains : Mefenamic Acid Dicyclomine Hydrochloride Excipients qs |
IP IP | 250 mg 10 mg |
| 450 | Calcium Citrate, Vitamin D3 Magnesium Hydroxide, Zinc Sulphate tablet. | Each Film Coated Tablet Contains: Calcium Citrate Magnesium Hydroxide Eq. to Magnesium Vitamin D3 Zinc Sulphate Monohydrate Eq. to Zinc Excipients q.s Approved colour used |
USP IP IP IP | 1000 mg 100 mg 200 IU 4 mg |
| 451 | Fluconazole Tablets IP | Each Uncoated Tablet Contains: Fluconazole Excipients qs | IP | 150 mg |
| 452 | Levocetirizine Hydrochloride and Montelukast Tablets IP | Each Film Coated Tablet Contains: Levocetirizine Dihydrochloride Montelukast Sodium Eq. to Montelukast Approved colour used Excipients qs | IP IP | 5 mg 10 mg |
| 453 | Levofloxacin Tablets IP | Each Film Coated Tablet Contains: Levofloxacin Hemihydrate Eq. to Levofloxacin Approved colour used Excipients qs | IP | 750 mg |
| 454 | Ofloxacin and Ornidazole tablets IP | Each Film Coated Tablet Contains: Ofloxacin Ornidazole Approved Colour used Excipients qs |
IP IP | 200 mg 500 mg |
